Effect of p53 Activity on the Sensitivity of Human Glioblastoma Cells to PARP-1 Inhibitor in Combination with Topoisomerase I Inhibitor or Radiation (315 views visite)
Cytom Part A (ISSN: 1552-4922), 2014 Nov; 85A(11): 953-961.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article, Research Support, Non-U. S. Gov'T,
Impact factor: 2.928, 5-year impact factor Impact factor a 5 anni: 3.091
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84906723326&partnerID=40&md5=ccaadd4d43fb990ec9f0e24fdcc3808e
Keywords Parole chiave: Combinatorial Strategy, Glioblastoma, P53, Parp Inhibitor, Radiotherapy, Topotecan,
Affiliations Affiliazioni:
*** IBB - CNR ***
Department of Clinical Medicine and SurgeryUniversity of Naples Federico II Via Sergio Pansini 5Naples Italy80131
Department of SurgeryMassachusetts General Hospital, Harvard Medical SchoolBoston, Massachusetts02114
Department of Molecular Medicine Medical BiotechnologyUniversity of Naples Federico IIVia Sergio Pansini 5Naples Italy80131
Department of Biomedical Advanced SciencesUniversity of Naples Federico II Via Sergio Pansini 5Naples Italy80131
Institute of Biostructures and Bioimaging CNRVia Sergio Pansini 5Naples Italy80131
Department of Diagnostic Imaging and Radiation OncologyUniversity of Naples Federico II Via Sergio Pansini 5Naples Italy80131
Faculty of Pharmacy and Medicine Department of MedicineUniversity of SalernoVia S. AllendeBaronissi (Salerno) Italy84131
References Riferimenti:
Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Bogdahn, U., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma (2005) N Engl J Med, 352, pp. 987-99
Ohgaki, H., Dessen, P., Jourde, B., Horstmann, S., Nishikawa, T., Di Patre, P.L., Burkhard, C., Maiorka, P.C., Genetic pathways to glioblastoma: a population-based study (2004) Cancer Res, 64, pp. 6892-6899
Wang, Y., Zhu, S., Cloughesy, T.F., Liau, L.M., Mischel, P.S., p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition (2004) Oncogene, 23, pp. 1283-1290
Sasine, J.P., Feun, L.G., Topoisomerase I inhibitors in the treatment of primary CNS malignancies: An update on recent trends (2011) Anticancer Agents Med Chem, 10, pp. 683-696
Pinel, S., Chastagner, P., Merlin, J.L., Marchal, C., Taghian, A., Barberi-Heyob, M., Topotecan can compensate for protracted radiation treatment time effects in high grade glioma xenografts (2006) J Neurooncol, 76, pp. 31-38
Fisher, B., Won, M., Macdonald, D., Johnson, D.W., Roa, W., Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group 9513 (2002) Int J Radiat Oncol Biol Phys, 53, pp. 980-986
Klautke, G., Schutze, M., Bombor, I., Benecke, R., Piek, J., Fietkau, R., Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme (2006) J Neurooncol, 77, pp. 199-205
Bernier-Chastagner, V., Grill, J., Doz, F., Bracard, S., Gentet, J.C., Marie-Cardine, A., Luporsi, E., Laithier, V., Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study (2005) Cancer, 104, pp. 2792-2797
Gross, M.W., Altscher, R., Brandtner, M., Haeusser-Mischlich, H., Chiricuta, I.C., Siegmann, A.D., Engenhart-Cabillic, R., Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults (2005) Clin Neurol Neurosurg, 107, pp. 207-213
Grabenbauer, G.G., Gerber, K.D., Ganslandt, O., Richter, A., Klautke, G., Birkmann, J., Meyer, M., Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme (2009) Int J Radiat Oncol Biol Phys, 75, pp. 164-169
Lesimple, T., Riffaud, L., Frappaz, D., Ben Hassel, M., Gedouin, D., Bay, J.O., Linassier, C., Fabbro, M., Topotecan in combination with radiotherapy in unresectable glioblastoma: A phase 2 study (2009) J Neurooncol, 93, pp. 253-260
Ratnam, K., Low, J.A., Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology (2007) Clin Cancer Res, 13, pp. 1383-1388
Wesierska-Gadek, J., Schmid, G., Cerni, C., ADP-ribosylation of wild-type p53 in vitro: Binding of p53 protein to specific p53 consensus sequence prevents its modification (1996) Biochem Biophys Res Commun, 224, pp. 96-102
Simbulan-Rosenthal, C.M., Rosenthal, D.S., Iyer, S., Boulares, A.H., Smulson, M.E., Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis (1998) J Biol Chem, 273, pp. 13703-13712
Griffin, R.J., Curtin, N.J., Newell, D.R., Golding, B.T., Durkacz, B.W., Calvert, A.H., The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapy (1995) Biochimie, 77, pp. 408-422
Bowman, K.J., Newell, D.R., Calvert, A.H., Curtin, N.J., Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro (2001) Br J Cancer, 84, pp. 106-112
Tentori, L., Portarena, I., Graziani, G., Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors (2002) Pharmacol Res, 45, pp. 73-85
Tentori, L., Graziani, G., Chemopotentiation by PARP inhibitors in cancer therapy (2005) Pharmacol Res, 52, pp. 25-33
Cimmino, G., Pepe, S., Laus, G., Chianese, M., Prece, D., Penitente, R., Quesada, P., Poly(ADPR)polymerase-1 signalling of the DNA damage induced by DNA topoisomerase I poison in D54(p53wt) and U251(p53mut) glioblastoma cell lines (2007) Pharmacol Res, 55, pp. 49-56
Sabisz, M., Wesierska-Gadek, J., Skladanowski, A., Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints (2010) Biochem Pharmacol, 79, pp. 1387-1397
Bao, S., Wu, Q., McLendon, R.E., Hao, Y., Shi, Q., Hjelmeland, A.B., Dewhirst, M.W., Rich, J.N., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response (2006) Nature, 444, pp. 756-760
Fuxe, J., Akusjarvi, G., Goike, H.M., Roos, G., Collins, V.P., Pettersson, R.F., Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A (2000) Cell Growth Differ, 11, pp. 373-384
Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays (1983) J Immunol Methods, 65, pp. 55-63
Burkle, A., Chen, G., Kupper, J.H., Grube, K., Zeller, W.J., Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment (1993) Carcinogenesis, 14, pp. 559-561
Jacobberger, J.W., Sramkoski, R.M., Stefan, T., Multiparameter cell cycle analysis (2011) Methods Mol Biol, 699, pp. 229-249
Huang, X., Halicka, H.D., Darzynkiewicz, Z., Detection of histone H2AX phosphorylation on Ser-139 as an indicator of DNA damage (DNA double-strand breaks) (2004) Curr Protoc Cytom, 7, p. 27. , Chapter 7
Hao, D.L., Liu, C.M., Dong, W.J., Gong, H., Wu, X.S., Liu, D.P., Liang, C.C., Knockdown of human p53 gene expression in 293-T cells by retroviral vector-mediated short hairpin RNA (2005) Acta Biochim Biophys Sin (Shanghai), 37, pp. 779-783
Sabbatino, F., Wang, Y., Wang, X., Flaherty, K.T., Yu, L., Pepin, D., Scognamiglio, G., Cooper, Z.A., PDGFRalpha up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation (2014) Oncotarget, 5, pp. 1926-1941
Piroth, M.D., Gagel, B., Pinkawa, M., Stanzel, S., Asadpour, B., Eble, M.J., Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors (2007) Strahlenther Onkol, 183, pp. 695-702
Durkacz, B.W., Omidiji, O., Gray, D.A., Shall, S., (ADP-ribose)n participates in DNA excision repair (1980) Nature, 283, pp. 593-596
Ueno, A.M., Tanaka, O., Matsudaira, H., Inhibition of gamma-ray dose-rate effects by D2O and inhibitors of poly(ADP-ribose) synthetase in cultured mammalian L5178Y cells (1984) Radiat Res, 98, pp. 574-582
Thraves, P., Mossman, K.L., Brennan, T., Dritschilo, A., Radiosensitization of human fibroblasts by 3-aminobenzamide: an inhibitor of poly(ADP-ribosylation) (1985) Radiat Res, 104, pp. 119-127
Kelland, L.R., Tonkin, K.S., The effect of 3-aminobenzamide in the radiation response of three human cervix carcinoma xenografts (1989) Radiother Oncol, 15, pp. 363-369
Papeo, G., Forte, B., Orsini, P., Perrera, C., Posteri, H., Scolaro, A., Montagnoli, A., Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity? (2009) Expert Opin Ther Pat, 19, pp. 1377-1400
Nguewa, P.A., Fuertes, M.A., Alonso, C., Perez, J.M., Pharmacological modulation of Poly(ADP-ribose) polymerase-mediated cell death: exploitation in cancer chemotherapy (2003) Mol Pharmacol, 64, pp. 1007-1014
Pilch, D.R., Sedelnikova, O.A., Redon, C., Celeste, A., Nussenzweig, A., Bonner, W.M., Characteristics of gamma-H2AX foci at DNA double-strand breaks sites (2003) Biochem Cell Biol, 81, pp. 123-129
Banath, J.P., Olive, P.L., Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks (2003) Cancer Res, 63, pp. 4347-4350
MacPhail, S.H., Banath, J.P., Yu, T.Y., Chu, E.H., Lambur, H., Olive, P.L., Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays (2003) Int J Radiat Biol, 79, pp. 351-358
Takahashi, R., Giannini, C., Sarkaria, J.N., Schroeder, M., Rogers, J., Mastroeni, D., Scrable, H., p53 isoform profiling in glioblastoma and injured brain (2012) Oncogene, 32, pp. 3165-3174
Gorczyca, W., Gong, J., Ardelt, B., Traganos, F., Darzynkiewicz, Z., The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents (1993) Cancer Res, 53, pp. 3186-3192
Martin, S., Janouskova, H., Dontenwill, M., Integrins and p53 pathways in glioblastoma resistance to temozolomide (2012) Front Oncol, 2, p. 157
Pena-Rico, M.A., Calvo-Vidal, M.N., Villalonga-Planells, R., Martinez-Soler, F., Gimenez-Bonafe, P., Navarro-Sabate, A., Tortosa, A., Manzano, A., TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells (2011) Radiother Oncol, 101, pp. 132-139
Puca, R., Nardinocchi, L., Porru, M., Simon, A.J., Rechavi, G., Leonetti, C., Givol, D., D'Orazi, G., Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs (2011) Cell Cycle, 10, pp. 1679-1689
Ruano, Y., Ribalta, T., de Lope, A.R., Campos-Martin, Y., Fiano, C., Perez-Magan, E., Hernandez-Moneo, J.L., Melendez, B., Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration (2009) Am J Clin Pathol, 131, pp. 257-263
Cytom Part A (ISSN: 1552-4922), 2014 Nov; 85A(11): 953-961.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article, Research Support, Non-U. S. Gov'T,
Impact factor: 2.928, 5-year impact factor Impact factor a 5 anni: 3.091
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-84906723326&partnerID=40&md5=ccaadd4d43fb990ec9f0e24fdcc3808e
Keywords Parole chiave: Combinatorial Strategy, Glioblastoma, P53, Parp Inhibitor, Radiotherapy, Topotecan,
Affiliations Affiliazioni:
*** IBB - CNR ***
Department of Clinical Medicine and SurgeryUniversity of Naples Federico II Via Sergio Pansini 5Naples Italy80131
Department of SurgeryMassachusetts General Hospital, Harvard Medical SchoolBoston, Massachusetts02114
Department of Molecular Medicine Medical BiotechnologyUniversity of Naples Federico IIVia Sergio Pansini 5Naples Italy80131
Department of Biomedical Advanced SciencesUniversity of Naples Federico II Via Sergio Pansini 5Naples Italy80131
Institute of Biostructures and Bioimaging CNRVia Sergio Pansini 5Naples Italy80131
Department of Diagnostic Imaging and Radiation OncologyUniversity of Naples Federico II Via Sergio Pansini 5Naples Italy80131
Faculty of Pharmacy and Medicine Department of MedicineUniversity of SalernoVia S. AllendeBaronissi (Salerno) Italy84131
References Riferimenti:
Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Bogdahn, U., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma (2005) N Engl J Med, 352, pp. 987-99
Ohgaki, H., Dessen, P., Jourde, B., Horstmann, S., Nishikawa, T., Di Patre, P.L., Burkhard, C., Maiorka, P.C., Genetic pathways to glioblastoma: a population-based study (2004) Cancer Res, 64, pp. 6892-6899
Wang, Y., Zhu, S., Cloughesy, T.F., Liau, L.M., Mischel, P.S., p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition (2004) Oncogene, 23, pp. 1283-1290
Sasine, J.P., Feun, L.G., Topoisomerase I inhibitors in the treatment of primary CNS malignancies: An update on recent trends (2011) Anticancer Agents Med Chem, 10, pp. 683-696
Pinel, S., Chastagner, P., Merlin, J.L., Marchal, C., Taghian, A., Barberi-Heyob, M., Topotecan can compensate for protracted radiation treatment time effects in high grade glioma xenografts (2006) J Neurooncol, 76, pp. 31-38
Fisher, B., Won, M., Macdonald, D., Johnson, D.W., Roa, W., Phase II study of topotecan plus cranial radiation for glioblastoma multiforme: Results of Radiation Therapy Oncology Group 9513 (2002) Int J Radiat Oncol Biol Phys, 53, pp. 980-986
Klautke, G., Schutze, M., Bombor, I., Benecke, R., Piek, J., Fietkau, R., Concurrent chemoradiotherapy and adjuvant chemotherapy with Topotecan for patients with glioblastoma multiforme (2006) J Neurooncol, 77, pp. 199-205
Bernier-Chastagner, V., Grill, J., Doz, F., Bracard, S., Gentet, J.C., Marie-Cardine, A., Luporsi, E., Laithier, V., Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study (2005) Cancer, 104, pp. 2792-2797
Gross, M.W., Altscher, R., Brandtner, M., Haeusser-Mischlich, H., Chiricuta, I.C., Siegmann, A.D., Engenhart-Cabillic, R., Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults (2005) Clin Neurol Neurosurg, 107, pp. 207-213
Grabenbauer, G.G., Gerber, K.D., Ganslandt, O., Richter, A., Klautke, G., Birkmann, J., Meyer, M., Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme (2009) Int J Radiat Oncol Biol Phys, 75, pp. 164-169
Lesimple, T., Riffaud, L., Frappaz, D., Ben Hassel, M., Gedouin, D., Bay, J.O., Linassier, C., Fabbro, M., Topotecan in combination with radiotherapy in unresectable glioblastoma: A phase 2 study (2009) J Neurooncol, 93, pp. 253-260
Ratnam, K., Low, J.A., Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology (2007) Clin Cancer Res, 13, pp. 1383-1388
Wesierska-Gadek, J., Schmid, G., Cerni, C., ADP-ribosylation of wild-type p53 in vitro: Binding of p53 protein to specific p53 consensus sequence prevents its modification (1996) Biochem Biophys Res Commun, 224, pp. 96-102
Simbulan-Rosenthal, C.M., Rosenthal, D.S., Iyer, S., Boulares, A.H., Smulson, M.E., Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis (1998) J Biol Chem, 273, pp. 13703-13712
Griffin, R.J., Curtin, N.J., Newell, D.R., Golding, B.T., Durkacz, B.W., Calvert, A.H., The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapy (1995) Biochimie, 77, pp. 408-422
Bowman, K.J., Newell, D.R., Calvert, A.H., Curtin, N.J., Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro (2001) Br J Cancer, 84, pp. 106-112
Tentori, L., Portarena, I., Graziani, G., Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors (2002) Pharmacol Res, 45, pp. 73-85
Tentori, L., Graziani, G., Chemopotentiation by PARP inhibitors in cancer therapy (2005) Pharmacol Res, 52, pp. 25-33
Cimmino, G., Pepe, S., Laus, G., Chianese, M., Prece, D., Penitente, R., Quesada, P., Poly(ADPR)polymerase-1 signalling of the DNA damage induced by DNA topoisomerase I poison in D54(p53wt) and U251(p53mut) glioblastoma cell lines (2007) Pharmacol Res, 55, pp. 49-56
Sabisz, M., Wesierska-Gadek, J., Skladanowski, A., Increased cytotoxicity of an unusual DNA topoisomerase II inhibitor compound C-1305 toward HeLa cells with downregulated PARP-1 activity results from re-activation of the p53 pathway and modulation of mitotic checkpoints (2010) Biochem Pharmacol, 79, pp. 1387-1397
Bao, S., Wu, Q., McLendon, R.E., Hao, Y., Shi, Q., Hjelmeland, A.B., Dewhirst, M.W., Rich, J.N., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response (2006) Nature, 444, pp. 756-760
Fuxe, J., Akusjarvi, G., Goike, H.M., Roos, G., Collins, V.P., Pettersson, R.F., Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A (2000) Cell Growth Differ, 11, pp. 373-384
Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays (1983) J Immunol Methods, 65, pp. 55-63
Burkle, A., Chen, G., Kupper, J.H., Grube, K., Zeller, W.J., Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment (1993) Carcinogenesis, 14, pp. 559-561
Jacobberger, J.W., Sramkoski, R.M., Stefan, T., Multiparameter cell cycle analysis (2011) Methods Mol Biol, 699, pp. 229-249
Huang, X., Halicka, H.D., Darzynkiewicz, Z., Detection of histone H2AX phosphorylation on Ser-139 as an indicator of DNA damage (DNA double-strand breaks) (2004) Curr Protoc Cytom, 7, p. 27. , Chapter 7
Hao, D.L., Liu, C.M., Dong, W.J., Gong, H., Wu, X.S., Liu, D.P., Liang, C.C., Knockdown of human p53 gene expression in 293-T cells by retroviral vector-mediated short hairpin RNA (2005) Acta Biochim Biophys Sin (Shanghai), 37, pp. 779-783
Sabbatino, F., Wang, Y., Wang, X., Flaherty, K.T., Yu, L., Pepin, D., Scognamiglio, G., Cooper, Z.A., PDGFRalpha up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation (2014) Oncotarget, 5, pp. 1926-1941
Piroth, M.D., Gagel, B., Pinkawa, M., Stanzel, S., Asadpour, B., Eble, M.J., Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors (2007) Strahlenther Onkol, 183, pp. 695-702
Durkacz, B.W., Omidiji, O., Gray, D.A., Shall, S., (ADP-ribose)n participates in DNA excision repair (1980) Nature, 283, pp. 593-596
Ueno, A.M., Tanaka, O., Matsudaira, H., Inhibition of gamma-ray dose-rate effects by D2O and inhibitors of poly(ADP-ribose) synthetase in cultured mammalian L5178Y cells (1984) Radiat Res, 98, pp. 574-582
Thraves, P., Mossman, K.L., Brennan, T., Dritschilo, A., Radiosensitization of human fibroblasts by 3-aminobenzamide: an inhibitor of poly(ADP-ribosylation) (1985) Radiat Res, 104, pp. 119-127
Kelland, L.R., Tonkin, K.S., The effect of 3-aminobenzamide in the radiation response of three human cervix carcinoma xenografts (1989) Radiother Oncol, 15, pp. 363-369
Papeo, G., Forte, B., Orsini, P., Perrera, C., Posteri, H., Scolaro, A., Montagnoli, A., Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity? (2009) Expert Opin Ther Pat, 19, pp. 1377-1400
Nguewa, P.A., Fuertes, M.A., Alonso, C., Perez, J.M., Pharmacological modulation of Poly(ADP-ribose) polymerase-mediated cell death: exploitation in cancer chemotherapy (2003) Mol Pharmacol, 64, pp. 1007-1014
Pilch, D.R., Sedelnikova, O.A., Redon, C., Celeste, A., Nussenzweig, A., Bonner, W.M., Characteristics of gamma-H2AX foci at DNA double-strand breaks sites (2003) Biochem Cell Biol, 81, pp. 123-129
Banath, J.P., Olive, P.L., Expression of phosphorylated histone H2AX as a surrogate of cell killing by drugs that create DNA double-strand breaks (2003) Cancer Res, 63, pp. 4347-4350
MacPhail, S.H., Banath, J.P., Yu, T.Y., Chu, E.H., Lambur, H., Olive, P.L., Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays (2003) Int J Radiat Biol, 79, pp. 351-358
Takahashi, R., Giannini, C., Sarkaria, J.N., Schroeder, M., Rogers, J., Mastroeni, D., Scrable, H., p53 isoform profiling in glioblastoma and injured brain (2012) Oncogene, 32, pp. 3165-3174
Gorczyca, W., Gong, J., Ardelt, B., Traganos, F., Darzynkiewicz, Z., The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents (1993) Cancer Res, 53, pp. 3186-3192
Martin, S., Janouskova, H., Dontenwill, M., Integrins and p53 pathways in glioblastoma resistance to temozolomide (2012) Front Oncol, 2, p. 157
Pena-Rico, M.A., Calvo-Vidal, M.N., Villalonga-Planells, R., Martinez-Soler, F., Gimenez-Bonafe, P., Navarro-Sabate, A., Tortosa, A., Manzano, A., TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells (2011) Radiother Oncol, 101, pp. 132-139
Puca, R., Nardinocchi, L., Porru, M., Simon, A.J., Rechavi, G., Leonetti, C., Givol, D., D'Orazi, G., Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs (2011) Cell Cycle, 10, pp. 1679-1689
Ruano, Y., Ribalta, T., de Lope, A.R., Campos-Martin, Y., Fiano, C., Perez-Magan, E., Hernandez-Moneo, J.L., Melendez, B., Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration (2009) Am J Clin Pathol, 131, pp. 257-263
Effect of p53 Activity on the Sensitivity of Human Glioblastoma Cells to PARP-1 Inhibitor in Combination with Topoisomerase I Inhibitor or Radiation
Poly (ADP-Ribose) polymerase-1 (PARP-1) is involved in the DNA repairing system by sensing and signaling the presence of DNA damage. Inhibition of PARP-1 is tested in combination with DNA damaging agents such as topoisomerase I inhibitors or ionizing radiations (RT) for the treatment of glioblastoma (GBM). Disruption of p53, widely prevalent in GBMs, plays a major role in DNA repairing system. The current study investigates whether p53 activity has an effect on the sensitivity of human GBM cells to PARP-1 inhibitors in combination with topoisomerase I inhibitor topotecan (TPT) and/or RT. Human GBM cell lines carrying a different functional status of p53 were treated with PARP-1 inhibitor NU1025, in combination with TPT and/or RT. Cytotoxic effects were examined by analyzing the antiproliferative activity, the cell cycle perturbations, and the DNA damage induced by combined treatments. PARP inhibition enhanced the antiproliferative activity, the cell cycle perturbations and the DNA damage induced by both TPT or RT in GBM cells. These effects were influenced by the p53 activity: cells carrying an active p53 were more sensitive to the combination of PARP inhibitor and RT, while cells carrying an inactive p53 displayed a higher sensitivity to the combination of PARP inhibitor and TPT. Our study suggests that p53 activity influences the differential sensitivity of GBM cells to combined treatments of TPT, RT, and PARP inhibitors. (c) 2014 International Society for Advancement of Cytometry
Poly (ADP-Ribose) polymerase-1 (PARP-1) is involved in the DNA repairing system by sensing and signaling the presence of DNA damage. Inhibition of PARP-1 is tested in combination with DNA damaging agents such as topoisomerase I inhibitors or ionizing radiations (RT) for the treatment of glioblastoma (GBM). Disruption of p53, widely prevalent in GBMs, plays a major role in DNA repairing system. The current study investigates whether p53 activity has an effect on the sensitivity of human GBM cells to PARP-1 inhibitors in combination with topoisomerase I inhibitor topotecan (TPT) and/or RT. Human GBM cell lines carrying a different functional status of p53 were treated with PARP-1 inhibitor NU1025, in combination with TPT and/or RT. Cytotoxic effects were examined by analyzing the antiproliferative activity, the cell cycle perturbations, and the DNA damage induced by combined treatments. PARP inhibition enhanced the antiproliferative activity, the cell cycle perturbations and the DNA damage induced by both TPT or RT in GBM cells. These effects were influenced by the p53 activity: cells carrying an active p53 were more sensitive to the combination of PARP inhibitor and RT, while cells carrying an inactive p53 displayed a higher sensitivity to the combination of PARP inhibitor and TPT. Our study suggests that p53 activity influences the differential sensitivity of GBM cells to combined treatments of TPT, RT, and PARP inhibitors. (c) 2014 International Society for Advancement of Cytometry
Effect of p53 Activity on the Sensitivity of Human Glioblastoma Cells to PARP-1 Inhibitor in Combination with Topoisomerase I Inhibitor or Radiation
| ▼ Brain segmentation for radiation oncology application Segmentazione cerebrale per applicazioni in radiologia oncologica |
Effect of p53 Activity on the Sensitivity of Human Glioblastoma Cells to PARP-1 Inhibitor in Combination with Topoisomerase I Inhibitor or Radiation
Cella L, Gagliardi G, Hedman M, Palma G
* Injuries From Asymptomatic COVID-19 Disease: New Hidden Toxicity Risk Factors in Thoracic Radiation Therapy (48 visite) (PDF 11 visite)
Int J Radiat Oncol Biol Phys (ISSN: 0360-3016linking), 2020 Oct 1; 108(2): 394-396.
Impact Factor: 5.859
Dettagli Esporta in BibTeX Esporta in EndNote
D'Alterio C, Zannetti A, Trotta AM, Ieranò C, Napolitano M, Rea G, Greco A, Maiolino P, Albanese S, Scognamiglio G, Tatangelo F, Tafuto S, Portella L, Santagata S, Nasti G, Ottaiano A, Pacelli R, Delrio P, Botti G, Scala S
* New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer (115 visite) (PDF 34 visite)
Cancers (ISSN: 2072-6694linking), 2020 Jul 18; 12(7): 1952-1952.
Impact Factor: 6.126
Dettagli Esporta in BibTeX Esporta in EndNote
Monti S, Paganelli C, Buizza G, Preda L, Valvo F, Baroni G, Palma G, Cella L
* A novel framework for spatial normalization of dose distributions in voxel-based analyses of brain irradiation outcomes (27 visite)
Phys Med (ISSN: 1120-1797linking), 2020 Jan; 69: 164-169.
Impact Factor: 2.485
Dettagli Esporta in BibTeX Esporta in EndNote
Liuzzi R, Piccolo C, D’avino V, Clemente S, Oliviero C, Cella L, Pugliese M
* Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy (67 visite)
Dose Response (ISSN: 1559-3258electronic, 1559-3258linking), 2020 Jan; 18(1): 1559325819894081-1559325819894081.
Impact Factor: 2.438
Dettagli Esporta in BibTeX Esporta in EndNote
Palma G, Monti S, Cella L
* Voxel-based analysis in radiation oncology: A methodological cookbook (45 visite)
Phys Med (ISSN: 1120-1797linking), 2020 Jan; 69: 192-204.
Impact Factor: 2.485
Dettagli Esporta in BibTeX Esporta in EndNote
Mercurio V, Cuomo A, Della Pepa R, Ciervo D, Cella L, Pirozzi F, Parrella P, Campi G, Franco R, Varricchi G, Abete P, Marone G, Petretta M, Bonaduce D, Pacelli R, Picardi M, Tocchetti CG
* What Is the Cardiac Impact of Chemotherapy and Subsequent Radiotherapy in Lymphoma Patients? (151 visite)
Antioxid Redox Signal (ISSN: 1523-0864linking, 1557-7716), 2019 Nov 20; 31 (15 ): 1166-1174.
Impact Factor: 7.581
Dettagli Esporta in BibTeX Esporta in EndNote
Palma G, Monti S, Xu T, Scifoni E, Yang P, Hahn SM, Durante M, Mohan R, Liao Z, Cella L
* Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer (100 visite)
Int J Radiat Oncol Biol Phys (ISSN: 0360-3016linking), 2019 Aug 1; 104(5): 1124-1132.
Impact Factor: 5.859
Dettagli Esporta in BibTeX Esporta in EndNote
Palma G, Monti S, Conson M, Pacelli R, Cella L
* Normal tissue complication probability (NTCP) models for modern radiation therapy (90 visite)
Semin Oncol (ISSN: 0093-7754linking), 2019 Jun; 46(3): 210-218.
Impact Factor: 3.606
Dettagli Esporta in BibTeX Esporta in EndNote
Fellin F, Iacco M, D'Avino V, Tommasino F, Farace P, Palma G, Conson M, Giacomelli I, Zucchetti C, Falcinelli L, Amichetti M, Aristei C, Cella L
* Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement (111 visite)
Acta Oncol (ISSN: 0284-186xlinking), 2019 Jun; 58 (6 ): 934-942.
Impact Factor: 2.997
Dettagli Esporta in BibTeX Esporta in EndNote
Pacelli R, Caroprese M, Palma G, Oliviero C, Clemente S, Cella L, Conson M
* Technological evolution of radiation treatment: Implications for clinical applications (102 visite)
Semin Oncol (ISSN: 0093-7754linking), 2019 Jun; 46(3): 193-201.
Impact Factor: 3.606
Dettagli Esporta in BibTeX Esporta in EndNote
Palma G, Cella L
* A new formalism of Dose Surface Histograms for robust modeling of skin toxicity in radiation therapy (89 visite)
Phys Med (ISSN: 1120-1797linking), 2019 Mar; 59: 75-78.
Impact Factor: 2.485
Dettagli Esporta in BibTeX Esporta in EndNote
Perri F, Ionna F, Muto P, Marzo MD, Caponigro F, Longo F, Vittoria Scarpati GD, Lorenzo GD, Giuliano M, Solla R
* Genetics and management of locally advanced carcinomas of the head and neck: role of altered fractionation radiotherapy (183 visite)
Future Sci Oa (ISSN: 2056-5623linking), 2018 Oct 26; 5(1): FSO347-FSO347.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Clemente S, Oliviero C, Palma G, D'Avino V, Liuzzi R, Conson M, Pacelli R, Cella L
* Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatment (187 visite)
Radiat Oncol (ISSN: 1748-717xlinking), 2018 Oct 19; 13(1): 202-202.
Impact Factor: 2.862
Dettagli Esporta in BibTeX Esporta in EndNote
Russo M, Malandrino P, Moleti M, Vermiglio F, D'Angelo A, La Rosa G, Sapuppo G, Calaciura F, Regalbuto C, Belfiore A, Vigneri R, Pellegriti G
* Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors (229 visite)
Pediatr Blood Cancer (ISSN: 1545-5009linking), 2018 Sep; 65(9): e27226-e27226.
Impact Factor: 2.513
Dettagli Esporta in BibTeX Esporta in EndNote
Cennamo G, Rossi C, Breve MA, Velotti N, Farella A, Liuzzi R, Cennamo G
* Evaluation of vascular changes with optical coherence tomography angiography after ruthenium-106 brachytherapy of circumscribed choroidal hemangioma (191 visite)
Eye (ISSN: 0950-222xlinking, 1476-5454electronic), 2018 Aug; 32(8): 1401-1405.
Impact Factor: 2.275
Dettagli Esporta in BibTeX Esporta in EndNote
Cennamo G, Breve MA, Velotti N, Sparnelli F, Iovino C, Farella A, Liuzzi R, De Crecchio G, Cennamo G
* Evaluation of Vascular Changes with Optical Coherence Tomography Angiography after Plaque Radiotherapy of Choroidal Melanoma (197 visite)
Ophthalmic Res (ISSN: 0030-3747linking), 2018 May; 60(4): 238-242.
Impact Factor: 1.826
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore B, D'Amico D, Fonti R
* Metastasis to the Sellar/Suprasellar Region in a Patient With Endometrial Carcinoma Detected by 18F-FDG PET/CT (219 visite)
Clin Nucl Med (ISSN: 1536-0229electronic, 0363-9762linking), 2018 May; 43(5): 363-364.
Impact Factor: 0.253
Dettagli Esporta in BibTeX Esporta in EndNote
Monti S, Pacelli R, Cella L, Palma G
* Inter-patient image registration algorithms to disentangle regional dose bioeffects (292 visite) (PDF 153 visite)
Sci Rep (ISSN: 2045-2322linking), 2018 Mar 20; 8(1): 4915-4918.
Impact Factor: 4.259
Dettagli Esporta in BibTeX Esporta in EndNote
Perri F, Longo F, Della Vittoria Scarpati G, Pisconti S, Longo V, Addeo R, Carducci F, Buonerba C, Fulciniti F, Solla R
* Metastatic HPV-related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment (270 visite)
Clin Case Rep (ISSN: 2050-0904print, 2050-0904linking), 2017 Nov 24; 6(1): 56-62.
Impact Factor: 0.54
Dettagli Esporta in BibTeX Esporta in EndNote
Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R
* Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience (322 visite)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2017 Nov 06; 59(1): 90-101.
Impact Factor: 3.179
Dettagli Esporta in BibTeX Esporta in EndNote
Alterio D, Gerardi MA, Cella L, Spoto R, Zurlo V, Sabbatini A, Fodor C, D'Avino V, Conson M, Valoriani F, Ciardo D, Pacelli R, Ferrari A, Maisonneuve P, Preda L, Bruschini R, Cossu Rocca M, Rondi E, Colangione S, Palma G, Dicuonzo S, Orecchia R, Sanguineti G, Jereczek-fossa BA
* Radiation-induced acute dysphagia: Prospective observational study on 42 head and neck cancer patients (414 visite)
Strahlenther Onkol (ISSN: 0179-7158, 0179-7158linking), 2017 Sep 07; 193(11): 971-981.
Impact Factor: 2.459
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Romanelli P, Conson M, D'Avino V, Ottaviano M, Damiano V, Palmieri G, Pacelli R, Mancini M
* Predictors of Asymptomatic Radiation-induced Abdominal Atherosclerosis (274 visite)
Clin Oncol (ISSN: 0936-6555, 0936-6555linking), 2017 Aug 10; 29(11): e186-e186.
Impact Factor: 3.06
Dettagli Esporta in BibTeX Esporta in EndNote
Monti S, Palma G, D'Avino V, Gerardi M, Marvaso G, Ciardo D, Pacelli R, Jereczek-fossa BA, Alterio D, Cella L
* Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients (470 visite)
Sci Rep (ISSN: 2045-2322, 2045-2322electronic, 2045-2322linking), 2017 Aug 03; 7(1): 7220-7220.
Impact Factor: 4.122
Dettagli Esporta in BibTeX Esporta in EndNote
Tommasino F, Durante M, D'Avino V, Liuzzi R, Conson M, Farace P, PalmaG, Schwarz M, Cella L, Pacelli R
* Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery (236 visite)
Acta Oncol (ISSN: 0284-186x, 0284-186xlinking), 2017 May; 56(5): 730-736.
Impact Factor: 3.473
Dettagli Esporta in BibTeX Esporta in EndNote
Perri F, Addeo R, Conson M, Faiella A, Scarpati GDV, Torre G, Di Biase A, Romanelli P, Buonerba C, Di Lorenzo G, Daponte A, Caponigro F, Pisconti S, Pacelli R, Ravo V, Muto P, Solla R
* Locally advanced paranasal sinus carcinoma: A study of 30 patients (207 visite)
Oncol Lett (ISSN: 1792-1074), 2017 Mar; 13(3): 1338-1342.
Impact Factor: 1.664
Dettagli Esporta in BibTeX Esporta in EndNote
Tommasino F, Nahum A, Cella L
* Increasing the power of tumour control and normal tissue complication probability modelling in radiotherapy: recent trends and current issues (437 visite) (PDF 138 visite)
Transl Cancer Res, 2017; N/D: N/D-N/D.
Impact Factor: 1.167
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, D'Avino V, Palma G, Conson M, Liuzzi R, Picardi M, Pressello MC, Boboc GI, Battistini R, Donato V, Pacelli R
* Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung (349 visite) (PDF 190 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887), 2015 Aug 12; 117(1): 36-43.
Impact Factor: 4.817
Dettagli Esporta in BibTeX Esporta in EndNote
Perri F, Pisconti S, Conson M, Pacelli R, Della Vittoria Scarpati G, Gnoni A, D'Aniello C, Cavaliere C, Licchetta A, Cella L, Giuliano M, Schiavone C, Falivene S, Di Lorenzo G, Buonerba C, Ravo V, Muto P
* Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen (244 visite)
Oncotargets Ther (ISSN: 1178-6930, 1178-6930linking), 2015 Jun 8; 8: 1345-1349.
Impact Factor: 2.272
Dettagli Esporta in BibTeX Esporta in EndNote
D'Avino V, Palma G, Liuzzi R, Conson M, Doria F, Salvatore M, Pacelli R, Cella L
* Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer (354 visite)
Radiat Oncol (ISSN: 1748-717x), 2015 Apr 8; 10(1): 80-80.
Impact Factor: 2.466
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Oh JH, Deasy JO, Palma G, Liuzzi R, D'Avino V, Conson M, Picardi M, Salvatore M, Pacelli R
* Predicting radiation-induced valvular heart damage (294 visite)
Acta Oncol (ISSN: 0284-186x, 0284-186xlinking), 2015 Mar 24; 54(10): 1796-1804.
Impact Factor: 3.73
Dettagli Esporta in BibTeX Esporta in EndNote
Napolitano M, D'Alterio C, Cardone E, Trotta AM, Pecori B, Rega D, Pace U, Scala D, Scognamiglio G, Tatangelo F, Cacciapuoti C, Pacelli R, Delrio P, Scala S
* Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients (320 visite)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic), 2015; 6(10): 8261-8270.
Impact Factor: 5.008
Dettagli Esporta in BibTeX Esporta in EndNote
Perri F, Pacelli R, Della Vittoria Scarpati G, Cella L, Giuliano M, Caponigro F, Pepe S
* Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications (393 visite)
Head Neck-J Sci Spec (ISSN: 1043-3074), 2015; 37(5): 763-770.
Impact Factor: 2.76
Dettagli Esporta in BibTeX Esporta in EndNote
Formicola F, Riccardi A, Vigliar E, Biondi B, Accurso A, Del Vecchio W, Imbriaco M
* Multimetastatic medullary thyroid carcinoma to the breast: PET/CT--mammographic-US and MR findings (233 visite)
Breast J (ISSN: 1075-122x), 2014 Nov; 20(6): 653-654.
Impact Factor: 1.411
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Palma G, Deasy JO, Oh JH, Liuzzi R, D'Avino V, Conson M, Pugliese N, Picardi M, Salvatore M, Pacelli R
* Complication probability models for radiation-induced heart valvular dysfunction: Do heart-lung interactions play a role? (378 visite) (PDF 199 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2014 Oct 31; 9(10): 11175301-11175311.
Impact Factor: 3.234
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Fiorentino A, Simeon V, Tini P, Chiumento C, Pirtoli L, Salvatore M, Storto G
* Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes (335 visite)
Strahlenther Onkol (ISSN: 0179-7158), 2014 Oct; 190(10): 925-932.
Impact Factor: 2.914
Dettagli Esporta in BibTeX Esporta in EndNote
Conson M, Cella L, Pacelli R, Comerci M, Liuzzi R, Salvatore M, Quarantelli M
* Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: From atlas to dose-volume histograms (734 visite) (PDF 361 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887, 0167-8140linking), 2014 Sep; 112(3): 326-331.
Impact Factor: 4.363
Dettagli Esporta in BibTeX Esporta in EndNote
D'Alterio C, Avallone A, Tatangelo F, Delrio P, Pecori B, Cella L, Pelella A, D'Armiento FP, Carlomagno C, Bianco F, Silvestro L, Pacelli R, Napolitano M, Iaffaioli RV, Scala S
* A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients (334 visite)
Int J Cancer (ISSN: 0020-7136), 2014 Jul 15; 135(2): 379-390.
Impact Factor: 5.085
Dettagli Esporta in BibTeX Esporta in EndNote
Gallicchio R, Giacomobono S, Nardelli A, Pellegrino T, Simeon V, Gattozzi D, Maddalena F, Mainenti PP, Storto G
* Palliative Treatment Of Bone Metastases With Samarium-153 Edtmp At Onset Of Pain (346 visite)
J Bone Miner Metab (ISSN: 0914-8779), 2014 Jul; 32(4): 434-440.
Impact Factor: 2.46
Dettagli Esporta in BibTeX Esporta in EndNote
Orditura M, Galizia G, Di Martino N, Ancona E, Castoro C, Pacelli R, Morgillo F, Rossetti S, Gambardella V, Farella A, Laterza MM, Ruol A, Fabozzi A, Napolitano V, Iovino F, Lieto E, Fei L, Conzo G, Ciardiello F, De Vita F
* Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study (1830 visite)
Curr Oncol (ISSN: 1198-0052), 2014 Jun; 21(3): 125-133.
Impact Factor: 1.785
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, D'Avino V, Conson M, Di Biase A, Picardi M, Pugliese N, Solla R, Salvatore M, Pacelli R
* Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury (286 visite)
Acta Oncol (ISSN: 0284-186x), 2014 May; 53(5): 613-619.
Impact Factor: 2.997
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Strigari L, Benassi M, Caivano R, Fiorentino A, Nappi A, Salvatore M, Storto G
* Critical dose and toxicity index of organs at risk in radiotherapy: analyzing the calculated effects of modified dose fractionation in non-small cell lung cancer (383 visite)
Med Dosim (ISSN: 0958-3947, 1873-4022), 2014 Mar; 39(1): 23-30.
Impact Factor: 0.76
Dettagli Esporta in BibTeX Esporta in EndNote
Nold-Petry CA, Rudloff I, Baumer Y, Ruvo M, Marasco D, Botti P, Farkas L, Cho SX, Zepp JA, Azam T, Dinkel H, Palmer BE, Boisvert WA, Cool CD, Taraseviciene-Stewart L, Heinhuis B, Joosten LA, Dinarello CA, Voelkel NF, Nold MF
* IL-32 Promotes Angiogenesis (544 visite)
J Immunol (ISSN: 0022-1767), 2014 Jan 15; 192(2): 589-602.
Impact Factor: 4.922
Dettagli Esporta in BibTeX Esporta in EndNote
Di Biase A, Conson M, Cella L, Puglese N, Picardi M, Doria F, Solla R, Liuzzi R, Salvatore M, Pacelli R
* Efficacy And Toxicity Of Chemo-Radiotherapy In Hodgkins Lymphoma: A Single Institution Experience (323 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887), 2014; 111: 423-423.
Impact Factor: 4.363
Dettagli Esporta in BibTeX Esporta in EndNote
Avino S, D'Avino V, Giorgini A, Pacelli R, Liuzzi R, Cella L, Gagliardi G, De Natale P
* Radiation Dosimetry With Fiber Bragg Gratings (276 visite)
Proc Spie Int Soc Opt Eng (ISSN: 0277-786x, 0277-786x9781628411751), 2014; 9157: N/D-N/D.
Impact Factor: 0.958
Dettagli Esporta in BibTeX Esporta in EndNote
Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, Danoff A, Breen TL, Kaviani N, Shanik MH, LeRoith D, Vigneri R, Koch CA, Roth J
* Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive (1284 visite)
Endocrine Reviews (ISSN: 0163-769x), 2013 Dec; 34(6): 798-826.
Impact Factor: 19.358
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Fiorentino A, Improta G, Nappi A, Salvatore M, Storto G
* Estimate of the accelerated proliferation by protein tyrosine phosphatase (PTEN) over expression in postoperative radiotherapy of head and neck squamous cell carcinoma (272 visite)
Clin Transl Oncol (ISSN: 1699-048x), 2013 Nov; 15(11): 919-924.
Impact Factor: 1.6
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Conson M, D'Avino V, Salvatore M, Pacelli R
* Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors (333 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2013 Oct 1; 87(2): 304-310.
Impact Factor: 4.176
Dettagli Esporta in BibTeX Esporta in EndNote
Gramanzini M, Gargiulo S, Greco A, Feliciello A, Lignitto L, Brunetti A, Salvatore M
* 18F[FLT] PET and imaging post-processing for non -invasive assessment of siRNA treatment efficacy in experimental glioblastoma (336 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli Esporta in BibTeX Esporta in EndNote
Gallicchio R, Giacomobono S, Capacchione D, Nardelli A, Barbato F, Nappi A, Pellegrino T, Storto G
* Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? (326 visite)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
Impact Factor: 3.527
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, D'Avino V, Liuzzi R, Conson M, Doria F, Faiella A, Loffredo F, Salvatore M, Pacelli R
* Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer (333 visite)
Radiation Oncology (ISSN: 1748-717x), 2013 Sep 23; 8(1): 221-221.
Impact Factor: 2.36
Dettagli Esporta in BibTeX Esporta in EndNote
Passaro C, Abagnale A, Libertini S, Volpe M, Botta G, Cella L, Pacelli R, Halldèn G, Gillespie D, Portella G
* Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells (400 visite)
Endocr Relat Cancerendocrine Related Cancer (ISSN: 1351-0088), 2013 Sep 19; 20(5): 633-647.
Impact Factor: 4.907
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Gallicchio R, Pellegrino T, Nardelli A, Capacchione D, Sirignano C, Pace L
* Impact of F-18-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP (315 visite) (PDF 4 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897, 0969-8051linking), 2013 May; 40(4): 518-523.
Impact Factor: 2.408
Dettagli Esporta in BibTeX Esporta in EndNote
Lignitto L, Arcella A, Sepe M, Rinaldi L, Delle Donne R, Gallo A, Stefan E, Bachmann VA, Oliva MA, Tiziana Storlazzi C, L'Abbate A, Brunetti A, Gargiulo S, Gramanzini M, Insabato L, Garbi C, Gottesman ME, Feliciello A
* Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth (396 visite)
Nat Commun (ISSN: 2041-1723, 2041-1723electronic, 2041-1723linking), 2013 May; 4: 100-105.
Impact Factor: 10.742
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Strigari L, Caivano R, Fiorentino A, Califano G, Nappi A, Improta G, Storto G, Cozzolino M, Chiumento C, Fusco V, Vavassori A, Benassi M, Orecchia R, Salvatore M
* Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer (296 visite)
Journal Of Applied Clinical Medical Physics (ISSN: 1526-9914), 2013 Mar 04; 14(2): 4N/D-4N/D.
Impact Factor: 1.11
Dettagli Esporta in BibTeX Esporta in EndNote
Pacelli R, Conson M, Cella L, Liuzzi R, Troncone G, Iorio V, Solla R, Farella A, Scala S, Pagliarulo C, Salvatore M
* Radiation therapy following surgery for localized breast cancer: Outcome prediction by classical prognostic factors and approximated genetic subtypes (300 visite)
J Rad Res Journal Of Radiation Research (ISSN: 1349-9157, 0449-3060, 1349-9157electronic), 2013 Mar 1; 54(2): 292-298.
Impact Factor: 1.691
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Conson M, Pressello MC, Molinelli S, Schneider U, Donato V, Orecchia R, Salvatore M, Pacelli R
* Hodgkin's lymphoma emerging radiation treatment techniques: Trade-offs between late radio-induced toxicities and secondary malignant neoplasms (323 visite)
Radiat Oncol Radiation Oncology (ISSN: 1748-717x), 2013 Jan 30; 8(1): 22-22.
Impact Factor: 2.36
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Conson M, Liuzzi R, Pacelli R
* In regard to boomsma et al (337 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2013 Jan 1; 85(1): 11-11.
Impact Factor: 4.176
Dettagli Esporta in BibTeX Esporta in EndNote
Scalia M, Satriano C, Greca R, Stella AM, Rizzarelli E, Spina-Purrello V
* PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells (389 visite)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2013 Jan; 38(1): 50-58.
Impact Factor: 2.551
Dettagli Esporta in BibTeX Esporta in EndNote
Costa B, Bendinelli S, Gabelloni P, Da Pozzo E, Daniele S, Scatena F, Vanacore R, Campiglia P, Bertamino A, Gomez-Monterrey I, Sorriento D, Del Giudice C, Iaccarino G, Novellino E, Martini C
* Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor (310 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2013; 8(8): e72281-e72281.
Impact Factor: 3.534
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Conson M, D'Avino V, Salvatore M, Pacelli R
* Development of multivariate NTCP models for radiation-induced hypothyroidism: A comparative analysis (412 visite) (PDF 212 visite)
Radiat Oncol Radiation Oncology (ISSN: 1748-717x), 2012 Dec 27; 7(1): 224-224.
Impact Factor: 2.107
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Nappi A, Strigari L, Jereczek-Fossa BA, Alterio D, Cremonesi M, Botta F, Vischioni B, Caivano R, Fiorentino A, Improta G, Storto G, Benassi M, Orecchia R, Salvatore M
* Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma (394 visite)
Radiation Oncology (ISSN: 1748-717x), 2012 Sep 24; 7: 143-143.
Impact Factor: 2.107
Dettagli Esporta in BibTeX Esporta in EndNote
Elefante A, Peca C, Del Basso DCM, Russo C, Formicola F, Mariniello G, Brunetti A, Maiuri F
* Symptomatic spinal cord metastasis from cerebral oligodendroglioma (268 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2012 Jun; 33(3): 609-613.
Impact Factor: 1.412
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, Pacelli R
* Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma (431 visite) (PDF 212 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2012 Apr 1; 82(5): 1802-1808.
Impact Factor: 4.524
Dettagli Esporta in BibTeX Esporta in EndNote
Orditura M, Galizia G, Morgillo F, Martinelli E, Lieto E, Vitiello F, Di Martino N, Pacelli R, Renda A, Ciardiello F, De Vita F
* Complete Response To Preoperative Chemoradiation And Survival In Esophageal Cancer: A Pooled Analysis Of Three Single-Institution Phase Ii Trials (370 visite)
Diseases Of The Esophagus, 2012 Feb; 142(5): 130-136.
Impact Factor: 2.057
Dettagli Esporta in BibTeX Esporta in EndNote
Magliulo M, Cella L, Pacelli R
* Novel technique radio frequency identification (RFID) based to manage patient flow in a radiotherapy department (269 visite)
Proc Ieee Embs Int Conf Biomed Health Informatics (ISSN: 9781-4577, 9781-457721779), 2012; N/D: 972-975.
Impact Factor: 0.41
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Conson M, Torre G, Caterino M, De Rosa N, Picardi M, Camera L, Solla R, Farella A, Salvatore M, Pacelli R
* Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma (380 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887, 1879-0887electronic), 2011 Nov; 101(2): 316-321.
Impact Factor: 5.58
Dettagli Esporta in BibTeX Esporta in EndNote
Pacelli R, Cella L, Conson M, Tranfa F, Strianese D, Liuzzi R, Solla R, Farella A, Salvatore M, Bonavolonta G
* Fractionated stereotactic radiation therapy for orbital optic nerve sheath meningioma - a single institution experience and a short review of the literature (277 visite)
J Rad Res Journal Of Radiation Research (ISSN: 1349-9157electronic, 0449-3060linking), 2011; 52(1): 82-87.
Impact Factor: 1.683
Dettagli Esporta in BibTeX Esporta in EndNote
Strianese D, Tranfa F, Finelli M, De Renzo A, Staibano S, Schiemer R, Cardone D, Pacelli R, Perna F, Mascolo M, De Rosa G, Bonavolonta G
* Hepatitis C virus infection in ocular adnexal lymphomas (303 visite)
Arch Ophthalmol (ISSN: 1538-3601, 0003-9950), 2010 Oct; 128(10): 1295-1299.
Impact Factor: 3.516
Dettagli Esporta in BibTeX Esporta in EndNote
Gallucci G, Coccaro M, Storto G, Lapadula L, Tartarone A, Nappi A, Cammarota A, Buonerba C, Di Lorenzo G, Fusco V, Aieta M
* The clinical impact of a cardiologic follow-up in breast cancer survivors: an observational study (272 visite)
Int J Immunopathol Pharmacol (ISSN: 0394-6320), 2010 Oct; 23(4): 1221-1227.
Impact Factor: 2.685
Dettagli Esporta in BibTeX Esporta in EndNote
Orditura M, Galizia G, Napolitano V, Martinelli E, Pacelli R, Lieto E, Aurilio G, Vecchione L, Morgillo F, Catalano G, Ciardiello F, Del Genio A, Di Martino N, De Vita F
* Weekly Chemotherapy with Cisplatin and Paclitaxel and Concurrent Radiation Therapy as Preoperative Treatment in Locally Advanced Esophageal Cancer: A Phase II Study (280 visite)
Cancer Investigation (ISSN: 0735-7907), 2010 Oct; 28(8): 820-827.
Impact Factor: 2.39
Dettagli Esporta in BibTeX Esporta in EndNote
Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A
* In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging (426 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jul; 37(7): 1441-1448.
Impact Factor: 5.036
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Pizzuti LM, Lettieri A, Salvatore M
* PET/CT in cancer research: From preclinical to clinical applications (568 visite)
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2010 Jul; 5(4): 190-200.
Impact Factor: 4.02
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Salvatore M
* The Italian affair: The employment of parallel-plate ionization chambers for dose measurements in high dose-per-pulse IORT electron beams (360 visite)
Med Phys (ISSN: 0094-2405, 2473-4209electronic, 0094-2405linking), 2010 Jun; 37(6): 2918-2924.
Impact Factor: 3.075
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Magliulo M, Conson M, Camera L, Salvatore M, Pacelli R
* Radiotherapy of large target volumes in Hodgkin's lymphoma: Normal tissue sparing capability of forward IMRT versus conventional techniques (391 visite) (PDF 212 visite)
Radiat Oncol Radiation Oncology (ISSN: 1748-717x), 2010 May 11; 5(1): 33-33.
Impact Factor: 2.409
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (357 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Conson M, Liuzzi R, Caterino M, De Rosa N, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, Pacelli R
* Radiation Induced Thyroid Disorders After Radiotherapy For Hodgkin S Disease: A Dosimetric Analysis (343 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887, 1879-0887electronic), 2010; 96: N/D-N/D.
Impact Factor: 4.337
Dettagli Esporta in BibTeX Esporta in EndNote
De Cicco L, Cella L, Liuzzi R, Solla R, Farella A, Punzo G, Tranfa F, Strianese D, Conson M, Bonavolontà G, Salvatore M, Pacelli R
* Radiation therapy in primary orbital lymphoma: A single institution retrospective analysis (419 visite)
Radiat Oncol Radiation Oncology (ISSN: 1748-717x), 2009 Dec 7; 4(1): 60-60.
Impact Factor: 2.36
Dettagli Esporta in BibTeX Esporta in EndNote
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
* Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5) (445 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli Esporta in BibTeX Esporta in EndNote
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
* Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with α vβ5 (778 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli Esporta in BibTeX Esporta in EndNote
Peca C, Pacelli R, Elefante A, Del Basso De Caro ML, Vergara P, Mariniello G, Giamundo A, Maiuri F
* Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: Tumour progression or radionecrosis? (310 visite)
Clin Neurol Neurosurg (ISSN: 0303-8467), 2009 May; 111(4): 331-334.
Impact Factor: 1.303
Dettagli Esporta in BibTeX Esporta in EndNote
Carlomagno C, Farella A, Bucci L, D'Armiento FP, Pesce G, Pepe S, Cannella L, Pacelli R, De Stefano A, Solla R, D'Armiento MR, De Placido S
* Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: A phase II study (686 visite)
Annals Of Oncology (ISSN: 0923-7534), 2009 May; 20(5): 906-912.
Impact Factor: 5.647
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Nicolai E, Salvatore M
* [18F]FDG-PET-CT for early monitoring of tumor response: When and why (334 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009 Apr; 53(2): 167-180.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Ciscognetti N, Martin G, Liuzzi R, Punzo G, Solla R, Farella A, Salvatore M, Pacelli R
* Preoperative Radiation Treatment for Rectal Cancer: Comparison of Target Coverage and Small Bowel NTCP in Conventional vs. 3D-Conformal Planning (358 visite)
Med Dosim (ISSN: 0958-3947, 1873-4022), 2009 Mar; 34(1): 75-81.
Impact Factor: 1.256
Dettagli Esporta in BibTeX Esporta in EndNote
Liuzzi R, Salvatore M, Cella L
* Estimation of free electron fraction value p for a parallel-plate ionization chamber in high dose per pulse IORT electron beams (283 visite)
World Congress On Medical Physics And Biomedical Engineering (ISSN: 1680-07379783642034725), 2009; 25(1): 998-1000.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Magliulo M, Conson M, Camera L, Salvatore M, Pacelli R
* Optimization of dose distribution with multi-leaf collimator using field-in-field technique for radiotherapy of Hodgkin's lymphoma (329 visite)
World Congress On Medical Physics And Biomedical Engineering (ISSN: 1680-0737, 1680-07379783642034725), 2009; 25(1): 82-84.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Sabbatino F, Pacelli R, Punzo G, Fusciello C, Vernieri C, Della Vittoria Scarpati G, Pepe S
* Inhibition of poly (ADP-Ribose) polymerase synergizes with the DNA-topoisomerase-1-inhibitor, topotecan, and radiation in human glioblastoma cell lines (309 visite)
Cytom Part A (ISSN: 1552-4922), 2008 Jan; 73A(1): N/D-N/D.
Impact Factor: 3.259
Dettagli Esporta in BibTeX Esporta in EndNote
Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B
* Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans (338 visite)
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2007 Sep; 48(9): 1721-1727.
Impact Factor: 1.512
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (556 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, Califano C, Caparrotti G, Segreto S, Pace L, Rotoli B
* Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis (342 visite)
Ann Hematol (ISSN: 0939-5555, 0939-5555linking), 2007 Jun; 86(6): 415-423.
Impact Factor: 2.342
Dettagli Esporta in BibTeX Esporta in EndNote
Argenone A, De Cicco L, Totaro G, Di Stazio F, Gaetano M, Solla R, Punzo G, Cella L, Liuzzi R, Salvatore M, Pacelli R
* Radiotherapy in primary orbital lymphoma: Report on 48 cases of a single istutution experience (249 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887, 1879-0887electronic), 2006 Oct; 81: N/D-N/D.
Impact Factor: 3.97
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Acampa W, Varrone A, Salvatore M
* Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care (482 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Mar; 33(3): 360-381.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
Di Pietro C, Piro S, Tabbì G, Ragusa M, Di Pietro V, Zimmitti V, Cuda F, Anello M, Consoli U, Salinaro ET, Caruso M, Vancheri C, Crimi N, Sabini MG, Cirrone GA, Raffaele L, Privitera G, Pulvirenti A, Giugno R, Ferro A, Cuttone G, Lo Nigro S, Purrello R, Purrello F, Purrello M
* Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy (472 visite)
Apoptosis (ISSN: 1360-8185), 2006 Jan; 11(1): 57-66.
Impact Factor: 3.421
Dettagli Esporta in BibTeX Esporta in EndNote
d'Alesio V, Pacelli R, Durante M, Canale Cama G, Cella L, Gialanella G, Grossi G, Pugliese M, Punzo G, Sardi I, Scampoli P, Solla R, Salvatore M
* Lymph nodes in the irradiated field influence the yield of radiation-induced chromosomal aberrations in lymphocytes from breast cancer patients (290 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2003 Nov 1; 57(3): 732-738.
Impact Factor: 4.285
Dettagli Esporta in BibTeX Esporta in EndNote
Portella G, Pacelli R, Libertini S, Cella L, Vecchio G, Salvatore M, Fusco A
* ONYX-015 Enhances Radiation-Induced Death of Human Anaplastic Thyroid Carcinoma Cells (401 visite)
J Clin Endocrinol Metab Journal Of Clinical Endocrinology And Metabolism (ISSN: 0021-972x), 2003 Oct 1; 88(10): 5027-5032.
Impact Factor: 5.873
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Aloj L, Caracò C, Ciarmiello A, Salvatore M
* Inhibition of early Tc-99m-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma (478 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2003 Jun; 30(6): 879-887.
Impact Factor: 3.324
Dettagli Esporta in BibTeX Esporta in EndNote
Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R
* Potential role of IMRT and protons in the treatment of the breast and regional nodes (308 visite)
Int J Rad Oncol Biol Phys, 2003 Mar 1; 48(3Supplement): 785-792.
Impact Factor: 0.155
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Aloj L, Salvatore M
* MIBI as prognostic factor in breast cancer (404 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2003 Mar; 47(1): 46-50.
Impact Factor: 2.222
Dettagli Esporta in BibTeX Esporta in EndNote
Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R
* Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes (313 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2003; 55(3): 785-792.
Impact Factor: 4.285
Dettagli Esporta in BibTeX Esporta in EndNote
Miralbell R, Lomax A, Cella L, Schneider U
* Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors (244 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2002 Nov 1; 54(3): 824-829.
Impact Factor: 3.756
Dettagli Esporta in BibTeX Esporta in EndNote
Cama G, Vassallo P, Alberti D, Cante D, Solla R, Punzo G, Cella L, Pacelli R
* Primary non-Hodgkin's lymphoma of the lacrimal sac: A case report (357 visite)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 2002 Nov; 88(6): 530-531.
Impact Factor: 0.267
Dettagli Esporta in BibTeX Esporta in EndNote
Cante D, Solla R, Manzo R, Chianese E, Punzo G, Cella L, Vassallo P, Morra A, Alterio D, Alberti D, Pacelli R, Canale Cama G
* A case report of a primary NHL of the lacrimal sac (376 visite)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 2001 Jul; 87(4): 530-531.
Impact Factor: 0.49
Dettagli Esporta in BibTeX Esporta in EndNote
Canale Cama G, Cante D, Pacelli R, Solla R, Chianese E, Manzo R, Punzo G, Cella L, Morra A, Alterio D, Alberti D, Vassallo P, Salvatore M
* Radiotherapy in primary orbital lymphoma outcome and late side effects (243 visite)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 2001 Jul; 87(4): S120-S120.
Impact Factor: 0.49
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Lomax A, Miralbell R
* New techniques in hadrontherapy: Intensity modulated proton beams (236 visite)
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2001; 17(SUPPL.1): 100-102.
Impact Factor: 0.556
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Lomax A, Miralbell R
* Potential role of intensity modulated proton beams in prostate cancer radiotherapy (287 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2001; 49(1): 217-223.
Impact Factor: 3.327
Dettagli Esporta in BibTeX Esporta in EndNote
Miralbell R, Cella L, Weber D, Lomax A
Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams (292 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2000; 47(4): 1111-1119.
Impact Factor: 3.058
Dettagli Esporta in BibTeX Esporta in EndNote
Imbriaco M, De Iuri A, Camera L
Isolated uterine relapse in a child with acute lymphoblastic leukemia (197 visite)
Ajr Am J Roentgenol (ISSN: 0361-803x), 1998 Oct; 171(4): 1166-1167.
Impact Factor: 2.179
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore M, Del Vecchio S
Dynamic imaging: Scintimammography (357 visite)
Eur J Radiol Elsevier Sci Ireland Ltd (ISSN: 0720-048x), 1998 May; 27(SUPPL.2): S259-S259.
Impact Factor: 0.537
Dettagli Esporta in BibTeX Esporta in EndNote
Soricelli A, Cuocolo A, Varrone A, Discepolo A, Tedeschi E, Mainenti PP, Grivet-Fojaja MR, Covelli EM, Postiglione A, Salvatore M
Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: Comparison with thallium-201 imaging (371 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1998 May; 39(5): 802-806.
Impact Factor: 3.064
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Coucourde F, Malgieri F, Ragozzino A
PET/CT and radiotherapy (2395 visite)
Q J Nucl Med Mol Imaging, 1980 Oct; 50(1): 4-14.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Cella L, Gagliardi G, Hedman M, Palma G
* Injuries From Asymptomatic COVID-19 Disease: New Hidden Toxicity Risk Factors in Thoracic Radiation Therapy (48 visite) (PDF 11 visite)
Int J Radiat Oncol Biol Phys (ISSN: 0360-3016linking), 2020 Oct 1; 108(2): 394-396.
Impact Factor: 5.859
Dettagli Esporta in BibTeX Esporta in EndNote
D'Alterio C, Zannetti A, Trotta AM, Ieranò C, Napolitano M, Rea G, Greco A, Maiolino P, Albanese S, Scognamiglio G, Tatangelo F, Tafuto S, Portella L, Santagata S, Nasti G, Ottaiano A, Pacelli R, Delrio P, Botti G, Scala S
* New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer (115 visite) (PDF 34 visite)
Cancers (ISSN: 2072-6694linking), 2020 Jul 18; 12(7): 1952-1952.
Impact Factor: 6.126
Dettagli Esporta in BibTeX Esporta in EndNote
Monti S, Paganelli C, Buizza G, Preda L, Valvo F, Baroni G, Palma G, Cella L
* A novel framework for spatial normalization of dose distributions in voxel-based analyses of brain irradiation outcomes (27 visite)
Phys Med (ISSN: 1120-1797linking), 2020 Jan; 69: 164-169.
Impact Factor: 2.485
Dettagli Esporta in BibTeX Esporta in EndNote
Liuzzi R, Piccolo C, D’avino V, Clemente S, Oliviero C, Cella L, Pugliese M
* Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy (67 visite)
Dose Response (ISSN: 1559-3258electronic, 1559-3258linking), 2020 Jan; 18(1): 1559325819894081-1559325819894081.
Impact Factor: 2.438
Dettagli Esporta in BibTeX Esporta in EndNote
Palma G, Monti S, Cella L
* Voxel-based analysis in radiation oncology: A methodological cookbook (45 visite)
Phys Med (ISSN: 1120-1797linking), 2020 Jan; 69: 192-204.
Impact Factor: 2.485
Dettagli Esporta in BibTeX Esporta in EndNote
Mercurio V, Cuomo A, Della Pepa R, Ciervo D, Cella L, Pirozzi F, Parrella P, Campi G, Franco R, Varricchi G, Abete P, Marone G, Petretta M, Bonaduce D, Pacelli R, Picardi M, Tocchetti CG
* What Is the Cardiac Impact of Chemotherapy and Subsequent Radiotherapy in Lymphoma Patients? (151 visite)
Antioxid Redox Signal (ISSN: 1523-0864linking, 1557-7716), 2019 Nov 20; 31 (15 ): 1166-1174.
Impact Factor: 7.581
Dettagli Esporta in BibTeX Esporta in EndNote
Palma G, Monti S, Xu T, Scifoni E, Yang P, Hahn SM, Durante M, Mohan R, Liao Z, Cella L
* Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer (100 visite)
Int J Radiat Oncol Biol Phys (ISSN: 0360-3016linking), 2019 Aug 1; 104(5): 1124-1132.
Impact Factor: 5.859
Dettagli Esporta in BibTeX Esporta in EndNote
Palma G, Monti S, Conson M, Pacelli R, Cella L
* Normal tissue complication probability (NTCP) models for modern radiation therapy (90 visite)
Semin Oncol (ISSN: 0093-7754linking), 2019 Jun; 46(3): 210-218.
Impact Factor: 3.606
Dettagli Esporta in BibTeX Esporta in EndNote
Fellin F, Iacco M, D'Avino V, Tommasino F, Farace P, Palma G, Conson M, Giacomelli I, Zucchetti C, Falcinelli L, Amichetti M, Aristei C, Cella L
* Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement (111 visite)
Acta Oncol (ISSN: 0284-186xlinking), 2019 Jun; 58 (6 ): 934-942.
Impact Factor: 2.997
Dettagli Esporta in BibTeX Esporta in EndNote
Pacelli R, Caroprese M, Palma G, Oliviero C, Clemente S, Cella L, Conson M
* Technological evolution of radiation treatment: Implications for clinical applications (102 visite)
Semin Oncol (ISSN: 0093-7754linking), 2019 Jun; 46(3): 193-201.
Impact Factor: 3.606
Dettagli Esporta in BibTeX Esporta in EndNote
Palma G, Cella L
* A new formalism of Dose Surface Histograms for robust modeling of skin toxicity in radiation therapy (89 visite)
Phys Med (ISSN: 1120-1797linking), 2019 Mar; 59: 75-78.
Impact Factor: 2.485
Dettagli Esporta in BibTeX Esporta in EndNote
Perri F, Ionna F, Muto P, Marzo MD, Caponigro F, Longo F, Vittoria Scarpati GD, Lorenzo GD, Giuliano M, Solla R
* Genetics and management of locally advanced carcinomas of the head and neck: role of altered fractionation radiotherapy (183 visite)
Future Sci Oa (ISSN: 2056-5623linking), 2018 Oct 26; 5(1): FSO347-FSO347.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Clemente S, Oliviero C, Palma G, D'Avino V, Liuzzi R, Conson M, Pacelli R, Cella L
* Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatment (187 visite)
Radiat Oncol (ISSN: 1748-717xlinking), 2018 Oct 19; 13(1): 202-202.
Impact Factor: 2.862
Dettagli Esporta in BibTeX Esporta in EndNote
Russo M, Malandrino P, Moleti M, Vermiglio F, D'Angelo A, La Rosa G, Sapuppo G, Calaciura F, Regalbuto C, Belfiore A, Vigneri R, Pellegriti G
* Differentiated thyroid cancer in children: Heterogeneity of predictive risk factors (229 visite)
Pediatr Blood Cancer (ISSN: 1545-5009linking), 2018 Sep; 65(9): e27226-e27226.
Impact Factor: 2.513
Dettagli Esporta in BibTeX Esporta in EndNote
Cennamo G, Rossi C, Breve MA, Velotti N, Farella A, Liuzzi R, Cennamo G
* Evaluation of vascular changes with optical coherence tomography angiography after ruthenium-106 brachytherapy of circumscribed choroidal hemangioma (191 visite)
Eye (ISSN: 0950-222xlinking, 1476-5454electronic), 2018 Aug; 32(8): 1401-1405.
Impact Factor: 2.275
Dettagli Esporta in BibTeX Esporta in EndNote
Cennamo G, Breve MA, Velotti N, Sparnelli F, Iovino C, Farella A, Liuzzi R, De Crecchio G, Cennamo G
* Evaluation of Vascular Changes with Optical Coherence Tomography Angiography after Plaque Radiotherapy of Choroidal Melanoma (197 visite)
Ophthalmic Res (ISSN: 0030-3747linking), 2018 May; 60(4): 238-242.
Impact Factor: 1.826
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore B, D'Amico D, Fonti R
* Metastasis to the Sellar/Suprasellar Region in a Patient With Endometrial Carcinoma Detected by 18F-FDG PET/CT (219 visite)
Clin Nucl Med (ISSN: 1536-0229electronic, 0363-9762linking), 2018 May; 43(5): 363-364.
Impact Factor: 0.253
Dettagli Esporta in BibTeX Esporta in EndNote
Monti S, Pacelli R, Cella L, Palma G
* Inter-patient image registration algorithms to disentangle regional dose bioeffects (292 visite) (PDF 153 visite)
Sci Rep (ISSN: 2045-2322linking), 2018 Mar 20; 8(1): 4915-4918.
Impact Factor: 4.259
Dettagli Esporta in BibTeX Esporta in EndNote
Perri F, Longo F, Della Vittoria Scarpati G, Pisconti S, Longo V, Addeo R, Carducci F, Buonerba C, Fulciniti F, Solla R
* Metastatic HPV-related oropharyngeal carcinoma cured with chemoradiotherapy: importance of pretherapy biomolecular assessment (270 visite)
Clin Case Rep (ISSN: 2050-0904print, 2050-0904linking), 2017 Nov 24; 6(1): 56-62.
Impact Factor: 0.54
Dettagli Esporta in BibTeX Esporta in EndNote
Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R
* Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience (322 visite)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2017 Nov 06; 59(1): 90-101.
Impact Factor: 3.179
Dettagli Esporta in BibTeX Esporta in EndNote
Alterio D, Gerardi MA, Cella L, Spoto R, Zurlo V, Sabbatini A, Fodor C, D'Avino V, Conson M, Valoriani F, Ciardo D, Pacelli R, Ferrari A, Maisonneuve P, Preda L, Bruschini R, Cossu Rocca M, Rondi E, Colangione S, Palma G, Dicuonzo S, Orecchia R, Sanguineti G, Jereczek-fossa BA
* Radiation-induced acute dysphagia: Prospective observational study on 42 head and neck cancer patients (414 visite)
Strahlenther Onkol (ISSN: 0179-7158, 0179-7158linking), 2017 Sep 07; 193(11): 971-981.
Impact Factor: 2.459
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Romanelli P, Conson M, D'Avino V, Ottaviano M, Damiano V, Palmieri G, Pacelli R, Mancini M
* Predictors of Asymptomatic Radiation-induced Abdominal Atherosclerosis (274 visite)
Clin Oncol (ISSN: 0936-6555, 0936-6555linking), 2017 Aug 10; 29(11): e186-e186.
Impact Factor: 3.06
Dettagli Esporta in BibTeX Esporta in EndNote
Monti S, Palma G, D'Avino V, Gerardi M, Marvaso G, Ciardo D, Pacelli R, Jereczek-fossa BA, Alterio D, Cella L
* Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients (470 visite)
Sci Rep (ISSN: 2045-2322, 2045-2322electronic, 2045-2322linking), 2017 Aug 03; 7(1): 7220-7220.
Impact Factor: 4.122
Dettagli Esporta in BibTeX Esporta in EndNote
Tommasino F, Durante M, D'Avino V, Liuzzi R, Conson M, Farace P, PalmaG, Schwarz M, Cella L, Pacelli R
* Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery (236 visite)
Acta Oncol (ISSN: 0284-186x, 0284-186xlinking), 2017 May; 56(5): 730-736.
Impact Factor: 3.473
Dettagli Esporta in BibTeX Esporta in EndNote
Perri F, Addeo R, Conson M, Faiella A, Scarpati GDV, Torre G, Di Biase A, Romanelli P, Buonerba C, Di Lorenzo G, Daponte A, Caponigro F, Pisconti S, Pacelli R, Ravo V, Muto P, Solla R
* Locally advanced paranasal sinus carcinoma: A study of 30 patients (207 visite)
Oncol Lett (ISSN: 1792-1074), 2017 Mar; 13(3): 1338-1342.
Impact Factor: 1.664
Dettagli Esporta in BibTeX Esporta in EndNote
Tommasino F, Nahum A, Cella L
* Increasing the power of tumour control and normal tissue complication probability modelling in radiotherapy: recent trends and current issues (437 visite) (PDF 138 visite)
Transl Cancer Res, 2017; N/D: N/D-N/D.
Impact Factor: 1.167
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, D'Avino V, Palma G, Conson M, Liuzzi R, Picardi M, Pressello MC, Boboc GI, Battistini R, Donato V, Pacelli R
* Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung (349 visite) (PDF 190 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887), 2015 Aug 12; 117(1): 36-43.
Impact Factor: 4.817
Dettagli Esporta in BibTeX Esporta in EndNote
Perri F, Pisconti S, Conson M, Pacelli R, Della Vittoria Scarpati G, Gnoni A, D'Aniello C, Cavaliere C, Licchetta A, Cella L, Giuliano M, Schiavone C, Falivene S, Di Lorenzo G, Buonerba C, Ravo V, Muto P
* Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen (244 visite)
Oncotargets Ther (ISSN: 1178-6930, 1178-6930linking), 2015 Jun 8; 8: 1345-1349.
Impact Factor: 2.272
Dettagli Esporta in BibTeX Esporta in EndNote
D'Avino V, Palma G, Liuzzi R, Conson M, Doria F, Salvatore M, Pacelli R, Cella L
* Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer (354 visite)
Radiat Oncol (ISSN: 1748-717x), 2015 Apr 8; 10(1): 80-80.
Impact Factor: 2.466
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Oh JH, Deasy JO, Palma G, Liuzzi R, D'Avino V, Conson M, Picardi M, Salvatore M, Pacelli R
* Predicting radiation-induced valvular heart damage (294 visite)
Acta Oncol (ISSN: 0284-186x, 0284-186xlinking), 2015 Mar 24; 54(10): 1796-1804.
Impact Factor: 3.73
Dettagli Esporta in BibTeX Esporta in EndNote
Napolitano M, D'Alterio C, Cardone E, Trotta AM, Pecori B, Rega D, Pace U, Scala D, Scognamiglio G, Tatangelo F, Cacciapuoti C, Pacelli R, Delrio P, Scala S
* Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients (320 visite)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic), 2015; 6(10): 8261-8270.
Impact Factor: 5.008
Dettagli Esporta in BibTeX Esporta in EndNote
Perri F, Pacelli R, Della Vittoria Scarpati G, Cella L, Giuliano M, Caponigro F, Pepe S
* Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications (393 visite)
Head Neck-J Sci Spec (ISSN: 1043-3074), 2015; 37(5): 763-770.
Impact Factor: 2.76
Dettagli Esporta in BibTeX Esporta in EndNote
Formicola F, Riccardi A, Vigliar E, Biondi B, Accurso A, Del Vecchio W, Imbriaco M
* Multimetastatic medullary thyroid carcinoma to the breast: PET/CT--mammographic-US and MR findings (233 visite)
Breast J (ISSN: 1075-122x), 2014 Nov; 20(6): 653-654.
Impact Factor: 1.411
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Palma G, Deasy JO, Oh JH, Liuzzi R, D'Avino V, Conson M, Pugliese N, Picardi M, Salvatore M, Pacelli R
* Complication probability models for radiation-induced heart valvular dysfunction: Do heart-lung interactions play a role? (378 visite) (PDF 199 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2014 Oct 31; 9(10): 11175301-11175311.
Impact Factor: 3.234
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Fiorentino A, Simeon V, Tini P, Chiumento C, Pirtoli L, Salvatore M, Storto G
* Clinical radiobiology of glioblastoma multiforme: estimation of tumor control probability from various radiotherapy fractionation schemes (335 visite)
Strahlenther Onkol (ISSN: 0179-7158), 2014 Oct; 190(10): 925-932.
Impact Factor: 2.914
Dettagli Esporta in BibTeX Esporta in EndNote
Conson M, Cella L, Pacelli R, Comerci M, Liuzzi R, Salvatore M, Quarantelli M
* Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: From atlas to dose-volume histograms (734 visite) (PDF 361 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887, 0167-8140linking), 2014 Sep; 112(3): 326-331.
Impact Factor: 4.363
Dettagli Esporta in BibTeX Esporta in EndNote
D'Alterio C, Avallone A, Tatangelo F, Delrio P, Pecori B, Cella L, Pelella A, D'Armiento FP, Carlomagno C, Bianco F, Silvestro L, Pacelli R, Napolitano M, Iaffaioli RV, Scala S
* A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients (334 visite)
Int J Cancer (ISSN: 0020-7136), 2014 Jul 15; 135(2): 379-390.
Impact Factor: 5.085
Dettagli Esporta in BibTeX Esporta in EndNote
Gallicchio R, Giacomobono S, Nardelli A, Pellegrino T, Simeon V, Gattozzi D, Maddalena F, Mainenti PP, Storto G
* Palliative Treatment Of Bone Metastases With Samarium-153 Edtmp At Onset Of Pain (346 visite)
J Bone Miner Metab (ISSN: 0914-8779), 2014 Jul; 32(4): 434-440.
Impact Factor: 2.46
Dettagli Esporta in BibTeX Esporta in EndNote
Orditura M, Galizia G, Di Martino N, Ancona E, Castoro C, Pacelli R, Morgillo F, Rossetti S, Gambardella V, Farella A, Laterza MM, Ruol A, Fabozzi A, Napolitano V, Iovino F, Lieto E, Fei L, Conzo G, Ciardiello F, De Vita F
* Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study (1830 visite)
Curr Oncol (ISSN: 1198-0052), 2014 Jun; 21(3): 125-133.
Impact Factor: 1.785
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, D'Avino V, Conson M, Di Biase A, Picardi M, Pugliese N, Solla R, Salvatore M, Pacelli R
* Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury (286 visite)
Acta Oncol (ISSN: 0284-186x), 2014 May; 53(5): 613-619.
Impact Factor: 2.997
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Strigari L, Benassi M, Caivano R, Fiorentino A, Nappi A, Salvatore M, Storto G
* Critical dose and toxicity index of organs at risk in radiotherapy: analyzing the calculated effects of modified dose fractionation in non-small cell lung cancer (383 visite)
Med Dosim (ISSN: 0958-3947, 1873-4022), 2014 Mar; 39(1): 23-30.
Impact Factor: 0.76
Dettagli Esporta in BibTeX Esporta in EndNote
Nold-Petry CA, Rudloff I, Baumer Y, Ruvo M, Marasco D, Botti P, Farkas L, Cho SX, Zepp JA, Azam T, Dinkel H, Palmer BE, Boisvert WA, Cool CD, Taraseviciene-Stewart L, Heinhuis B, Joosten LA, Dinarello CA, Voelkel NF, Nold MF
* IL-32 Promotes Angiogenesis (544 visite)
J Immunol (ISSN: 0022-1767), 2014 Jan 15; 192(2): 589-602.
Impact Factor: 4.922
Dettagli Esporta in BibTeX Esporta in EndNote
Di Biase A, Conson M, Cella L, Puglese N, Picardi M, Doria F, Solla R, Liuzzi R, Salvatore M, Pacelli R
* Efficacy And Toxicity Of Chemo-Radiotherapy In Hodgkins Lymphoma: A Single Institution Experience (323 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887), 2014; 111: 423-423.
Impact Factor: 4.363
Dettagli Esporta in BibTeX Esporta in EndNote
Avino S, D'Avino V, Giorgini A, Pacelli R, Liuzzi R, Cella L, Gagliardi G, De Natale P
* Radiation Dosimetry With Fiber Bragg Gratings (276 visite)
Proc Spie Int Soc Opt Eng (ISSN: 0277-786x, 0277-786x9781628411751), 2014; 9157: N/D-N/D.
Impact Factor: 0.958
Dettagli Esporta in BibTeX Esporta in EndNote
Dynkevich Y, Rother KI, Whitford I, Qureshi S, Galiveeti S, Szulc AL, Danoff A, Breen TL, Kaviani N, Shanik MH, LeRoith D, Vigneri R, Koch CA, Roth J
* Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive (1284 visite)
Endocrine Reviews (ISSN: 0163-769x), 2013 Dec; 34(6): 798-826.
Impact Factor: 19.358
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Fiorentino A, Improta G, Nappi A, Salvatore M, Storto G
* Estimate of the accelerated proliferation by protein tyrosine phosphatase (PTEN) over expression in postoperative radiotherapy of head and neck squamous cell carcinoma (272 visite)
Clin Transl Oncol (ISSN: 1699-048x), 2013 Nov; 15(11): 919-924.
Impact Factor: 1.6
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Conson M, D'Avino V, Salvatore M, Pacelli R
* Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors (333 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2013 Oct 1; 87(2): 304-310.
Impact Factor: 4.176
Dettagli Esporta in BibTeX Esporta in EndNote
Gramanzini M, Gargiulo S, Greco A, Feliciello A, Lignitto L, Brunetti A, Salvatore M
* 18F[FLT] PET and imaging post-processing for non -invasive assessment of siRNA treatment efficacy in experimental glioblastoma (336 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli Esporta in BibTeX Esporta in EndNote
Gallicchio R, Giacomobono S, Capacchione D, Nardelli A, Barbato F, Nappi A, Pellegrino T, Storto G
* Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? (326 visite)
Endocrine (ISSN: 1355-008x, 1355-008xlinking), 2013 Oct; 44(2): 426-433.
Impact Factor: 3.527
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, D'Avino V, Liuzzi R, Conson M, Doria F, Faiella A, Loffredo F, Salvatore M, Pacelli R
* Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer (333 visite)
Radiation Oncology (ISSN: 1748-717x), 2013 Sep 23; 8(1): 221-221.
Impact Factor: 2.36
Dettagli Esporta in BibTeX Esporta in EndNote
Passaro C, Abagnale A, Libertini S, Volpe M, Botta G, Cella L, Pacelli R, Halldèn G, Gillespie D, Portella G
* Ionizing radiation enhances dl922-947-mediated cell death of anaplastic thyroid carcinoma cells (400 visite)
Endocr Relat Cancerendocrine Related Cancer (ISSN: 1351-0088), 2013 Sep 19; 20(5): 633-647.
Impact Factor: 4.907
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Gallicchio R, Pellegrino T, Nardelli A, Capacchione D, Sirignano C, Pace L
* Impact of F-18-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP (315 visite) (PDF 4 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897, 0969-8051linking), 2013 May; 40(4): 518-523.
Impact Factor: 2.408
Dettagli Esporta in BibTeX Esporta in EndNote
Lignitto L, Arcella A, Sepe M, Rinaldi L, Delle Donne R, Gallo A, Stefan E, Bachmann VA, Oliva MA, Tiziana Storlazzi C, L'Abbate A, Brunetti A, Gargiulo S, Gramanzini M, Insabato L, Garbi C, Gottesman ME, Feliciello A
* Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth (396 visite)
Nat Commun (ISSN: 2041-1723, 2041-1723electronic, 2041-1723linking), 2013 May; 4: 100-105.
Impact Factor: 10.742
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Strigari L, Caivano R, Fiorentino A, Califano G, Nappi A, Improta G, Storto G, Cozzolino M, Chiumento C, Fusco V, Vavassori A, Benassi M, Orecchia R, Salvatore M
* Local tumor control probability to evaluate an applicator-guided volumetric-modulated arc therapy solution as alternative of 3D brachytherapy for the treatment of the vaginal vault in patients affected by gynecological cancer (296 visite)
Journal Of Applied Clinical Medical Physics (ISSN: 1526-9914), 2013 Mar 04; 14(2): 4N/D-4N/D.
Impact Factor: 1.11
Dettagli Esporta in BibTeX Esporta in EndNote
Pacelli R, Conson M, Cella L, Liuzzi R, Troncone G, Iorio V, Solla R, Farella A, Scala S, Pagliarulo C, Salvatore M
* Radiation therapy following surgery for localized breast cancer: Outcome prediction by classical prognostic factors and approximated genetic subtypes (300 visite)
J Rad Res Journal Of Radiation Research (ISSN: 1349-9157, 0449-3060, 1349-9157electronic), 2013 Mar 1; 54(2): 292-298.
Impact Factor: 1.691
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Conson M, Pressello MC, Molinelli S, Schneider U, Donato V, Orecchia R, Salvatore M, Pacelli R
* Hodgkin's lymphoma emerging radiation treatment techniques: Trade-offs between late radio-induced toxicities and secondary malignant neoplasms (323 visite)
Radiat Oncol Radiation Oncology (ISSN: 1748-717x), 2013 Jan 30; 8(1): 22-22.
Impact Factor: 2.36
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Conson M, Liuzzi R, Pacelli R
* In regard to boomsma et al (337 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2013 Jan 1; 85(1): 11-11.
Impact Factor: 4.176
Dettagli Esporta in BibTeX Esporta in EndNote
Scalia M, Satriano C, Greca R, Stella AM, Rizzarelli E, Spina-Purrello V
* PARP-1 inhibitors DPQ and PJ-34 negatively modulate proinflammatory commitment of human glioblastoma cells (389 visite)
Neurochemical Research (ISSN: 1573-6903, 0364-3190), 2013 Jan; 38(1): 50-58.
Impact Factor: 2.551
Dettagli Esporta in BibTeX Esporta in EndNote
Costa B, Bendinelli S, Gabelloni P, Da Pozzo E, Daniele S, Scatena F, Vanacore R, Campiglia P, Bertamino A, Gomez-Monterrey I, Sorriento D, Del Giudice C, Iaccarino G, Novellino E, Martini C
* Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor (310 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2013; 8(8): e72281-e72281.
Impact Factor: 3.534
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Conson M, D'Avino V, Salvatore M, Pacelli R
* Development of multivariate NTCP models for radiation-induced hypothyroidism: A comparative analysis (412 visite) (PDF 212 visite)
Radiat Oncol Radiation Oncology (ISSN: 1748-717x), 2012 Dec 27; 7(1): 224-224.
Impact Factor: 2.107
Dettagli Esporta in BibTeX Esporta in EndNote
Pedicini P, Nappi A, Strigari L, Jereczek-Fossa BA, Alterio D, Cremonesi M, Botta F, Vischioni B, Caivano R, Fiorentino A, Improta G, Storto G, Benassi M, Orecchia R, Salvatore M
* Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma (394 visite)
Radiation Oncology (ISSN: 1748-717x), 2012 Sep 24; 7: 143-143.
Impact Factor: 2.107
Dettagli Esporta in BibTeX Esporta in EndNote
Elefante A, Peca C, Del Basso DCM, Russo C, Formicola F, Mariniello G, Brunetti A, Maiuri F
* Symptomatic spinal cord metastasis from cerebral oligodendroglioma (268 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2012 Jun; 33(3): 609-613.
Impact Factor: 1.412
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, Pacelli R
* Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma (431 visite) (PDF 212 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2012 Apr 1; 82(5): 1802-1808.
Impact Factor: 4.524
Dettagli Esporta in BibTeX Esporta in EndNote
Orditura M, Galizia G, Morgillo F, Martinelli E, Lieto E, Vitiello F, Di Martino N, Pacelli R, Renda A, Ciardiello F, De Vita F
* Complete Response To Preoperative Chemoradiation And Survival In Esophageal Cancer: A Pooled Analysis Of Three Single-Institution Phase Ii Trials (370 visite)
Diseases Of The Esophagus, 2012 Feb; 142(5): 130-136.
Impact Factor: 2.057
Dettagli Esporta in BibTeX Esporta in EndNote
Magliulo M, Cella L, Pacelli R
* Novel technique radio frequency identification (RFID) based to manage patient flow in a radiotherapy department (269 visite)
Proc Ieee Embs Int Conf Biomed Health Informatics (ISSN: 9781-4577, 9781-457721779), 2012; N/D: 972-975.
Impact Factor: 0.41
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Conson M, Torre G, Caterino M, De Rosa N, Picardi M, Camera L, Solla R, Farella A, Salvatore M, Pacelli R
* Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin's lymphoma (380 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887, 1879-0887electronic), 2011 Nov; 101(2): 316-321.
Impact Factor: 5.58
Dettagli Esporta in BibTeX Esporta in EndNote
Pacelli R, Cella L, Conson M, Tranfa F, Strianese D, Liuzzi R, Solla R, Farella A, Salvatore M, Bonavolonta G
* Fractionated stereotactic radiation therapy for orbital optic nerve sheath meningioma - a single institution experience and a short review of the literature (277 visite)
J Rad Res Journal Of Radiation Research (ISSN: 1349-9157electronic, 0449-3060linking), 2011; 52(1): 82-87.
Impact Factor: 1.683
Dettagli Esporta in BibTeX Esporta in EndNote
Strianese D, Tranfa F, Finelli M, De Renzo A, Staibano S, Schiemer R, Cardone D, Pacelli R, Perna F, Mascolo M, De Rosa G, Bonavolonta G
* Hepatitis C virus infection in ocular adnexal lymphomas (303 visite)
Arch Ophthalmol (ISSN: 1538-3601, 0003-9950), 2010 Oct; 128(10): 1295-1299.
Impact Factor: 3.516
Dettagli Esporta in BibTeX Esporta in EndNote
Gallucci G, Coccaro M, Storto G, Lapadula L, Tartarone A, Nappi A, Cammarota A, Buonerba C, Di Lorenzo G, Fusco V, Aieta M
* The clinical impact of a cardiologic follow-up in breast cancer survivors: an observational study (272 visite)
Int J Immunopathol Pharmacol (ISSN: 0394-6320), 2010 Oct; 23(4): 1221-1227.
Impact Factor: 2.685
Dettagli Esporta in BibTeX Esporta in EndNote
Orditura M, Galizia G, Napolitano V, Martinelli E, Pacelli R, Lieto E, Aurilio G, Vecchione L, Morgillo F, Catalano G, Ciardiello F, Del Genio A, Di Martino N, De Vita F
* Weekly Chemotherapy with Cisplatin and Paclitaxel and Concurrent Radiation Therapy as Preoperative Treatment in Locally Advanced Esophageal Cancer: A Phase II Study (280 visite)
Cancer Investigation (ISSN: 0735-7907), 2010 Oct; 28(8): 820-827.
Impact Factor: 2.39
Dettagli Esporta in BibTeX Esporta in EndNote
Bombardieri E, Ambrosini V, Aktolun C, Baum RP, Bishof-delaloye A, Del Vecchio S, Maffioli L, Mortelmans L, Oyen W, Pepe G, Chiti A
* In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging (426 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Jul; 37(7): 1441-1448.
Impact Factor: 5.036
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Pizzuti LM, Lettieri A, Salvatore M
* PET/CT in cancer research: From preclinical to clinical applications (568 visite)
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2010 Jul; 5(4): 190-200.
Impact Factor: 4.02
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Salvatore M
* The Italian affair: The employment of parallel-plate ionization chambers for dose measurements in high dose-per-pulse IORT electron beams (360 visite)
Med Phys (ISSN: 0094-2405, 2473-4209electronic, 0094-2405linking), 2010 Jun; 37(6): 2918-2924.
Impact Factor: 3.075
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Magliulo M, Conson M, Camera L, Salvatore M, Pacelli R
* Radiotherapy of large target volumes in Hodgkin's lymphoma: Normal tissue sparing capability of forward IMRT versus conventional techniques (391 visite) (PDF 212 visite)
Radiat Oncol Radiation Oncology (ISSN: 1748-717x), 2010 May 11; 5(1): 33-33.
Impact Factor: 2.409
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P, Nardelli A, Speranza A, Klain M, Rotoli B, Pace L
* Assessment of Metabolic Response to Radioimmunotherapy with (90)Y-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (357 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 0033-8419linking), 2010 Jan; 254(1): 245-252.
Impact Factor: 6.069
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Conson M, Liuzzi R, Caterino M, De Rosa N, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, Pacelli R
* Radiation Induced Thyroid Disorders After Radiotherapy For Hodgkin S Disease: A Dosimetric Analysis (343 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887, 1879-0887electronic), 2010; 96: N/D-N/D.
Impact Factor: 4.337
Dettagli Esporta in BibTeX Esporta in EndNote
De Cicco L, Cella L, Liuzzi R, Solla R, Farella A, Punzo G, Tranfa F, Strianese D, Conson M, Bonavolontà G, Salvatore M, Pacelli R
* Radiation therapy in primary orbital lymphoma: A single institution retrospective analysis (419 visite)
Radiat Oncol Radiation Oncology (ISSN: 1748-717x), 2009 Dec 7; 4(1): 60-60.
Impact Factor: 2.36
Dettagli Esporta in BibTeX Esporta in EndNote
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
* Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5) (445 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli Esporta in BibTeX Esporta in EndNote
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
* Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with α vβ5 (778 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli Esporta in BibTeX Esporta in EndNote
Peca C, Pacelli R, Elefante A, Del Basso De Caro ML, Vergara P, Mariniello G, Giamundo A, Maiuri F
* Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: Tumour progression or radionecrosis? (310 visite)
Clin Neurol Neurosurg (ISSN: 0303-8467), 2009 May; 111(4): 331-334.
Impact Factor: 1.303
Dettagli Esporta in BibTeX Esporta in EndNote
Carlomagno C, Farella A, Bucci L, D'Armiento FP, Pesce G, Pepe S, Cannella L, Pacelli R, De Stefano A, Solla R, D'Armiento MR, De Placido S
* Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: A phase II study (686 visite)
Annals Of Oncology (ISSN: 0923-7534), 2009 May; 20(5): 906-912.
Impact Factor: 5.647
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Nicolai E, Salvatore M
* [18F]FDG-PET-CT for early monitoring of tumor response: When and why (334 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009 Apr; 53(2): 167-180.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Ciscognetti N, Martin G, Liuzzi R, Punzo G, Solla R, Farella A, Salvatore M, Pacelli R
* Preoperative Radiation Treatment for Rectal Cancer: Comparison of Target Coverage and Small Bowel NTCP in Conventional vs. 3D-Conformal Planning (358 visite)
Med Dosim (ISSN: 0958-3947, 1873-4022), 2009 Mar; 34(1): 75-81.
Impact Factor: 1.256
Dettagli Esporta in BibTeX Esporta in EndNote
Liuzzi R, Salvatore M, Cella L
* Estimation of free electron fraction value p for a parallel-plate ionization chamber in high dose per pulse IORT electron beams (283 visite)
World Congress On Medical Physics And Biomedical Engineering (ISSN: 1680-07379783642034725), 2009; 25(1): 998-1000.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Liuzzi R, Magliulo M, Conson M, Camera L, Salvatore M, Pacelli R
* Optimization of dose distribution with multi-leaf collimator using field-in-field technique for radiotherapy of Hodgkin's lymphoma (329 visite)
World Congress On Medical Physics And Biomedical Engineering (ISSN: 1680-0737, 1680-07379783642034725), 2009; 25(1): 82-84.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Sabbatino F, Pacelli R, Punzo G, Fusciello C, Vernieri C, Della Vittoria Scarpati G, Pepe S
* Inhibition of poly (ADP-Ribose) polymerase synergizes with the DNA-topoisomerase-1-inhibitor, topotecan, and radiation in human glioblastoma cell lines (309 visite)
Cytom Part A (ISSN: 1552-4922), 2008 Jan; 73A(1): N/D-N/D.
Impact Factor: 3.259
Dettagli Esporta in BibTeX Esporta in EndNote
Picardi M, De Renzo A, Pane F, Nicolai E, Pacelli R, Salvatore M, Rotoli B
* Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans (338 visite)
Leuk Lymphoma (ISSN: 1042-8194, 1026-8022linking), 2007 Sep; 48(9): 1721-1727.
Impact Factor: 1.512
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (556 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Catalano L, Del Vecchio S, Petruzziello F, Fonti R, Salvatore B, Martorelli C, Califano C, Caparrotti G, Segreto S, Pace L, Rotoli B
* Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis (342 visite)
Ann Hematol (ISSN: 0939-5555, 0939-5555linking), 2007 Jun; 86(6): 415-423.
Impact Factor: 2.342
Dettagli Esporta in BibTeX Esporta in EndNote
Argenone A, De Cicco L, Totaro G, Di Stazio F, Gaetano M, Solla R, Punzo G, Cella L, Liuzzi R, Salvatore M, Pacelli R
* Radiotherapy in primary orbital lymphoma: Report on 48 cases of a single istutution experience (249 visite)
Radiother Oncol (ISSN: 0167-8140, 1879-0887, 1879-0887electronic), 2006 Oct; 81: N/D-N/D.
Impact Factor: 3.97
Dettagli Esporta in BibTeX Esporta in EndNote
Cuocolo A, Acampa W, Varrone A, Salvatore M
* Highlights of the Annual Congress of the European Association of Nuclear Medicine, Istanbul, 2005: The incremental value of nuclear medicine for patient management and care (482 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Mar; 33(3): 360-381.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
Di Pietro C, Piro S, Tabbì G, Ragusa M, Di Pietro V, Zimmitti V, Cuda F, Anello M, Consoli U, Salinaro ET, Caruso M, Vancheri C, Crimi N, Sabini MG, Cirrone GA, Raffaele L, Privitera G, Pulvirenti A, Giugno R, Ferro A, Cuttone G, Lo Nigro S, Purrello R, Purrello F, Purrello M
* Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy (472 visite)
Apoptosis (ISSN: 1360-8185), 2006 Jan; 11(1): 57-66.
Impact Factor: 3.421
Dettagli Esporta in BibTeX Esporta in EndNote
d'Alesio V, Pacelli R, Durante M, Canale Cama G, Cella L, Gialanella G, Grossi G, Pugliese M, Punzo G, Sardi I, Scampoli P, Solla R, Salvatore M
* Lymph nodes in the irradiated field influence the yield of radiation-induced chromosomal aberrations in lymphocytes from breast cancer patients (290 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2003 Nov 1; 57(3): 732-738.
Impact Factor: 4.285
Dettagli Esporta in BibTeX Esporta in EndNote
Portella G, Pacelli R, Libertini S, Cella L, Vecchio G, Salvatore M, Fusco A
* ONYX-015 Enhances Radiation-Induced Death of Human Anaplastic Thyroid Carcinoma Cells (401 visite)
J Clin Endocrinol Metab Journal Of Clinical Endocrinology And Metabolism (ISSN: 0021-972x), 2003 Oct 1; 88(10): 5027-5032.
Impact Factor: 5.873
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Aloj L, Caracò C, Ciarmiello A, Salvatore M
* Inhibition of early Tc-99m-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma (478 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2003 Jun; 30(6): 879-887.
Impact Factor: 3.324
Dettagli Esporta in BibTeX Esporta in EndNote
Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R
* Potential role of IMRT and protons in the treatment of the breast and regional nodes (308 visite)
Int J Rad Oncol Biol Phys, 2003 Mar 1; 48(3Supplement): 785-792.
Impact Factor: 0.155
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Aloj L, Salvatore M
* MIBI as prognostic factor in breast cancer (404 visite)
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2003 Mar; 47(1): 46-50.
Impact Factor: 2.222
Dettagli Esporta in BibTeX Esporta in EndNote
Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R
* Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes (313 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2003; 55(3): 785-792.
Impact Factor: 4.285
Dettagli Esporta in BibTeX Esporta in EndNote
Miralbell R, Lomax A, Cella L, Schneider U
* Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors (244 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2002 Nov 1; 54(3): 824-829.
Impact Factor: 3.756
Dettagli Esporta in BibTeX Esporta in EndNote
Cama G, Vassallo P, Alberti D, Cante D, Solla R, Punzo G, Cella L, Pacelli R
* Primary non-Hodgkin's lymphoma of the lacrimal sac: A case report (357 visite)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 2002 Nov; 88(6): 530-531.
Impact Factor: 0.267
Dettagli Esporta in BibTeX Esporta in EndNote
Cante D, Solla R, Manzo R, Chianese E, Punzo G, Cella L, Vassallo P, Morra A, Alterio D, Alberti D, Pacelli R, Canale Cama G
* A case report of a primary NHL of the lacrimal sac (376 visite)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 2001 Jul; 87(4): 530-531.
Impact Factor: 0.49
Dettagli Esporta in BibTeX Esporta in EndNote
Canale Cama G, Cante D, Pacelli R, Solla R, Chianese E, Manzo R, Punzo G, Cella L, Morra A, Alterio D, Alberti D, Vassallo P, Salvatore M
* Radiotherapy in primary orbital lymphoma outcome and late side effects (243 visite)
Tumori (ISSN: 0300-8916, 0300-8916print, 0300-8916linking), 2001 Jul; 87(4): S120-S120.
Impact Factor: 0.49
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Lomax A, Miralbell R
* New techniques in hadrontherapy: Intensity modulated proton beams (236 visite)
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2001; 17(SUPPL.1): 100-102.
Impact Factor: 0.556
Dettagli Esporta in BibTeX Esporta in EndNote
Cella L, Lomax A, Miralbell R
* Potential role of intensity modulated proton beams in prostate cancer radiotherapy (287 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2001; 49(1): 217-223.
Impact Factor: 3.327
Dettagli Esporta in BibTeX Esporta in EndNote
Miralbell R, Cella L, Weber D, Lomax A
Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams (292 visite)
Int J Radiat Oncol (ISSN: 0360-3016, 1879-355x, 1879-355xelectronic), 2000; 47(4): 1111-1119.
Impact Factor: 3.058
Dettagli Esporta in BibTeX Esporta in EndNote
Imbriaco M, De Iuri A, Camera L
Isolated uterine relapse in a child with acute lymphoblastic leukemia (197 visite)
Ajr Am J Roentgenol (ISSN: 0361-803x), 1998 Oct; 171(4): 1166-1167.
Impact Factor: 2.179
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore M, Del Vecchio S
Dynamic imaging: Scintimammography (357 visite)
Eur J Radiol Elsevier Sci Ireland Ltd (ISSN: 0720-048x), 1998 May; 27(SUPPL.2): S259-S259.
Impact Factor: 0.537
Dettagli Esporta in BibTeX Esporta in EndNote
Soricelli A, Cuocolo A, Varrone A, Discepolo A, Tedeschi E, Mainenti PP, Grivet-Fojaja MR, Covelli EM, Postiglione A, Salvatore M
Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: Comparison with thallium-201 imaging (371 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1998 May; 39(5): 802-806.
Impact Factor: 3.064
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Coucourde F, Malgieri F, Ragozzino A
PET/CT and radiotherapy (2395 visite)
Q J Nucl Med Mol Imaging, 1980 Oct; 50(1): 4-14.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
109 Records (94 escludendo Abstract e Conferenze).
Impact factor totale: 342.539 (312.883 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 331.084 (297.858 escludendo Abstract e Conferenze).
Impact factor totale: 342.539 (312.883 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 331.084 (297.858 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:14:51
315 views visite. Last view on Ultima visita in data Tuesday 11 May 2021, 14:08:23
ibb.cnr.it